Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3008757	b-diffmik	— (—)	3090	10481	100.00%	Distribution not available
3008757	b-diff-mik	— (—)	1822	5197	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Any gastric operation

889

875

5.16

318.07

3.8

2.3

—

GASTRO-related operations

889

875

5.16

318.07

3.8

2.3

—

Second line medication for Crohn's disease

870

2133

4.17

315.76

3.8

3.5

—

Transplanted organ and tissue status

337

316

11.59

315.47

8.2

3.3

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1281

2712

3.37

309.81

4.4

3.2

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1221

1984

3.92

307.65

4.5

3.0

—

Pneumonias (Asthma/COPD co-morbidities)

1326

2659

3.51

307.65

4.5

3.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

809

850

10.24

307.65

7.6

3.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

1567

2027

4.44

307.65

3.9

3.2

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1534

2585

4.34

307.65

5.0

2.8

—

Oral corticosteroids

1492

2319

3.96

307.65

3.8

3.4

—

Septicaemia

842

1205

6.97

307.65

4.3

3.3

—

ILD medications

1670

2078

4.49

307.65

4.1

3.1

—

First line medication for Crohn's disease

1617

1941

4.62

307.65

4.1

3.2

—

Influenza and pneumonia

1377

2637

3.48

307.65

4.5

3.1

—

Inflammatory bowel disease treatment related agents

1604

2411

3.84

307.65

3.8

3.4

—

Bacterial infection, other or unspecified

1173

1487

7.40

307.65

5.0

3.2

—

Pneumonia, organism unspecified

1276

2488

3.77

307.65

4.4

3.1

—

All pneumoniae

1335

2682

3.49

307.65

4.5

3.1

—

ILD medications: immunosuppressive drugs

1116

1701

6.47

307.65

4.3

3.2

—

Fever of other and unknown origin

905

1819

4.72

307.65

5.4

3.2

—

Other diseases of blood and blood-forming organs, wide

523

804

6.83

307.65

6.9

3.6

—

Other septicaemia

776

1108

7.14

307.65

4.4

3.2

—

Primary_lymphoid and hematopoietic malignant neoplasms

809

722

12.07

307.65

7.6

3.0

—

1221

1984

3.92

307.65

4.5

3.0

—

Other bacterial diseases

1714

2166

5.61

307.65

4.4

3.1

—

Explicit Sepsis

859

1516

5.62

307.65

4.3

3.5

—

Lymphoid leukaemia

244

145

18.97

299.39

10.9

3.1

—

L04AX Other immunosuppressants

834

2104

4.05

291.14

3.8

3.5

—

Anaemias

379

225

11.48

287.03

4.9

2.0

—

Oxycodone

623

1272

4.88

271.43

3.9

3.7

—

Bacterial Sepsis

706

1460

4.41

265.53

4.3

3.6

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

325

367

9.36

264.53

5.7

3.0

—

Certain infectious and parasitic diseases

1100

1565

3.56

255.86

4.3

2.8

—

Lymphoid leukaemia

244

212

12.93

241.67

10.9

3.7

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

601

1190

4.54

233.93

3.1

3.0

—

Non-follicular lymphoma, hilmo, excluding all cancers

252

256

10.51

222.47

5.4

3.2

—

Malignant neoplasm

1030

1922

3.22

220.37

4.7

2.9

—

Implicit bacterial Sepsis

596

1330

4.21

213.35

4.4

3.6

—

Renal tubulo-interstitial diseases

1059

2786

2.96

212.57

4.0

3.5

—

Malignant neoplasm, wide definition for exclusion

995

1858

3.21

211.20

4.7

2.8

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

995

1858

3.21

211.19

4.7

2.8

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

994

1859

3.20

210.49

4.7

2.8

—

Agranulocytosis

284

366

8.23

207.92

6.7

3.3

—

Aplastic and other anaemias

681

1806

3.66

202.47

5.1

3.5

—

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

151

20.18

191.10

11.5

3.1

—

Medical observation and evaluation for suspected diseases and conditions

813

1206

3.49

186.17

3.9

3.4

—

Autoimmune diseases related-to ILD

975

3107

2.79

183.53

3.3

3.6

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

822

2543

3.05

182.23

4.4

3.5

—

ILD medications: azathioprine

250

326

7.92

180.17

3.9

3.1

—

Non-follicular lymphoma

252

350

7.67

173.15

5.4

4.0

—

Abnormal findings on diagnostic imaging of lung

662

1986

3.31

170.46

4.4

3.6

—

Autoimmune diseases excluding thyroid diseases

1150

2463

2.62

168.89

3.4

3.7

—

Any event in cancer register

974

2063

2.83

168.73

4.8

2.7

—

Other anaemias

601

1692

3.50

168.40

5.1

3.5

—

Infections, IBD-co-morbidities

285

289

7.38

167.85

5.6

3.5

—

Implicit Sepsis

830

2213

2.96

167.49

4.0

3.5

—

Other and unspecified anaemias

596

1684

3.50

166.88

5.1

3.5

—

Autoimmune diseases excluding thyroid diseases, strict definition

1117

2391

2.63

165.68

3.4

3.6

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

265

407

6.76

164.97

3.8

3.1

—

L04AA Selective immunosuppressants

364

765

4.91

161.62

5.2

3.8

—

Heart failure, not strict

901

2235

2.82

161.55

4.4

3.6

—

COPD/asthma related infections

1063

1984

2.71

161.01

4.2

3.0

—

COPD/asthma/ILD related infections

1063

1984

2.71

161.01

4.2

3.0

—

Renal failure

623

1743

3.34

159.62

4.6

3.7

—

Chronic lymphocytic leukaemia, helper endpoint

124

21.08

159.32

12.2

3.3

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

124

21.08

159.32

12.2

3.3

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

194

218

9.44

158.75

5.4

3.3

—

Azathioprine

250

377

6.84

158.09

3.9

—

General symptoms and signs

1127

2194

2.60

157.98

4.2

3.1

—

Any reimbursement code in KELA

511

582

4.44

156.89

3.7

2.0

—

Donors of organs and tissues

46.01

155.79

3.7

4.8

—

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

123

19.65

153.87

9.9

3.0

—

Multiple myeloma, excluding all cancers (controls excluding all cancers)

150

123

13.31

153.41

5.0

3.4

—

Erysipelas

579

1584

3.38

152.69

3.7

3.3

—

Multiple myeloma and malignant plasma cell neoplasms

148

122

13.23

150.86

5.0

3.4

—

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

119

19.68

148.73

12.2

3.3

—

Polyarthropathies

797

1868

2.88

147.33

3.6

3.8

—

Other and unspecified disorders of skin and subcutaneous tissue

176

208

9.02

138.65

4.5

3.8

—

Myeloid leukaemia

108

19.92

135.71

11.4

3.6

—

Dental caries

371

897

4.19

135.54

4.7

3.4

—

Complications of surgical and medical care, not elsewhere classified

1009

3086

2.37

129.61

4.3

3.4

—

Neoplasms

717

1316

2.95

129.12

4.4

2.3

—

Complications of medical and surgical care

793

2971

2.57

128.51

4.6

3.4

—

Chronic lymphocytic leukaemia

124

103

13.66

126.62

12.2

3.9

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

978

2815

2.38

125.85

5.0

3.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

842

2440

2.53

125.25

4.0

3.4

—

General examination and investigation of persons without complaint and reported diagnosis

674

1205

3.01

125.18

4.0

3.4

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

260

513

5.25

124.61

4.8

3.7

—

Dentinal caries

323

783

4.20

118.58

4.3

3.5

—

Deposits [accretions] on teeth

160

194

8.37

117.80

5.0

3.5

—

Autoimmune diseases

1091

2481

2.26

115.77

3.5

3.7

—

Secondary uncertain malignant neoplasm

240

477

5.23

114.24

4.3

4.0

—

Other pulmonary diagnosis

710

1289

2.78

113.28

4.3

3.0

—

Multiple myeloma and malignant plasma cell neoplasms

148

183

8.79

112.92

5.0

4.3

—

L04AD Calcineurin inhibitors

208

369

5.87

112.27

6.8

3.9

—

Secondary and unspecified malignant neoplasm of lymph nodes

189

307

6.48

111.96

4.6

3.9

—

Acute renal failure

307

754

4.18

111.94

4.6

3.8

—

Rare circulating lymphoid malignancy

123

122

11.22

111.37

9.9

4.6

—

Streptococcal septicaemia

152

196

8.07

110.96

3.6

—

Myeloid leukaemia

108

13.61

110.62

11.4

4.6

—

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

118

111

11.43

110.17

5.0

3.3

—

Diffuse large B-cell lymphoma, helper endpoint

118

111

11.43

110.17

5.0

3.3

—

Chronic periapical parodontitis

296

716

4.23

110.02

4.7

3.6

—

Myeloproliferative diseases

187

307

6.41

109.61

10.8

3.7

—

Excluding asthma or asthma-COPD overlap

701

1289

2.75

109.34

4.3

3.0

—

Implicit viral Sepsis

261

578

4.63

108.70

5.0

3.8

—

Viral Sepsis

261

578

4.63

108.69

5.0

3.8

—

Covid-19 confirmed case

372

1069

3.55

107.93

4.0

3.9

—

Enlarged lymph nodes

232

472

5.04

107.06

4.6

3.3

—

Tramadol

737

1898

2.52

105.26

3.4

3.5

—

Chronic kidney disease

397

1203

3.36

105.16

4.5

3.7

—

Other disorders of white blood cells

139

174

8.49

104.52

8.6

3.5

—

Diseases of pulp and periapical tissues

415

1308

3.22

103.72

4.2

3.4

—

Used for control exclusion in common control thyroid runs

1010

2315

2.23

103.31

3.7

3.6

—

Reimbursement for rheumatic diseases

616

2401

2.59

103.20

3.1

3.7

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

277

677

4.18

101.53

2.3

3.1

—

Systemic connective tissue disorders

430

1411

3.10

100.50

3.3

3.8

—

Acute tubulo-interstitial nephritis

641

2269

2.53

100.14

3.3

3.5

—

Persons encountering health services for specific procedures and health care

1024

2991

2.14

100.05

3.5

3.6

—

ILD differential diagnosis

687

1313

2.64

99.85

4.3

3.0

—

COPD differential diagnosis

687

1315

2.64

99.58

4.3

3.0

—

Continuous positive airway pressure

288

618

4.11

98.62

3.1

4.0

—

Purpura and other haemorrhagic conditions

226

484

4.83

98.43

6.5

3.8

—

Asthma, unspecified (mode), excluding more controls

436

1104

3.13

98.17

3.3

3.0

—

Other and unspecified disorders of white blood cells

115

125

9.89

96.86

9.5

3.5

—

Asthma, unspecified (mode)

449

1181

3.04

96.62

3.3

3.1

—

All influenza

298

796

3.81

96.38

5.2

3.5

—

Thrombocytopenia, unspecified

156

248

6.62

94.44

7.0

3.6

—

Sulfasalazine

303

837

3.68

93.21

2.8

3.7

—

Iron deficiency anaemia

471

1689

2.80

91.80

4.6

3.5

—

Explicit bacterial Sepsis

169

299

5.84

91.32

4.2

4.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

617

2546

2.44

91.26

4.7

3.5

—

Dialysis, with operation codes

207

440

4.86

91.01

4.4

3.9

—

Drug-induced neutropenia

150

238

6.62

90.97

4.5

4.0

—

Myeloproliferative diseases (CML excluded)

163

281

6.09

90.95

10.8

3.9

—

Care involving dialysis

157

262

6.26

90.43

3.5

4.7

—

Rheumatoid arthritis

382

1117

3.16

90.20

3.1

3.8

—

L01XX Other antineoplastic agents

139

208

7.11

89.42

11.8

4.0

—

Opioids

872

2079

2.22

89.31

3.7

3.4

—

COPD (mode)

324

734

3.56

88.94

3.1

3.3

—

Secondary hypertension

141

215

6.72

87.36

3.5

3.8

—

Fitting and adjustment of other devices

423

1372

2.92

87.34

3.6

4.0

—

Other bacterial intestinal infections

248

625

4.06

87.33

4.8

4.3

—

Nutritional anaemias

530

2038

2.56

86.41

4.5

3.5

—

Coagulation defects, purpura and other haemorrhagic conditions

264

704

3.84

85.88

6.0

3.9

—

Budesonide

170

322

5.40

85.15

3.1

3.9

—

Biological medication for rheuma

205

463

4.53

83.41

2.8

3.8

—

Bacterial intestinal infections, IBD co-morbidities

247

648

3.90

82.26

5.0

4.1

—

Hernia of abdominal wall, postoperative

156

282

5.62

82.04

3.6

2.9

—

5-aminosalicylic acid

225

557

4.10

80.98

3.3

3.9

—

Seropositive rheumatoid arthritis

301

907

3.37

80.81

3.2

3.8

—

6-mercaptopurine

13.15

80.16

5.2

3.0

—

Diffuse large B-cell lymphoma

118

167

7.57

80.04

5.0

4.8

—

Nephropathy related operations

198

452

4.52

79.77

4.5

4.4

—

Viral pneumonia

174

363

4.92

78.12

4.6

3.8

—

IBD patients in KELA-register

268

769

3.55

78.04

3.3

4.0

—

Finngen Rheumatological endpoints

850

2332

2.09

77.33

3.5

3.7

—

Acute myeloid leukaemia and myelodysplastic syndromes

14.04

77.30

12.3

3.9

—

Provisional assignment of new diseases of uncertain etiology

450

1740

2.62

77.22

4.1

3.5

—

Codes for special purposes

450

1746

2.61

76.68

4.1

3.5

—

Inflammatory bowel disease, strict (require KELA)

268

778

3.50

76.67

3.2

3.9

—

Oedema, not elsewhere classified

316

1019

3.13

75.36

3.5

3.4

—

Complications of procedures, not elsewhere classified

724

2971

2.12

75.11

3.7

3.4

—

Enterocolitis due to Clostridium difficile

172

368

4.82

75.08

5.7

3.9

—

Codeine

786

2033

2.14

74.90

3.6

3.4

—

Other special examinations and investigations of persons without complaint or reported diagnosis

583

1206

2.46

74.52

4.4

3.4

—

Polycythaemia vera

11.66

74.29

9.9

3.3

—

Other systemic involvement of connective tissue (FG)

284

870

3.29

73.67

3.1

3.9

—

Osteopathies and chondropathies

545

2228

2.35

73.15

3.9

3.6

—

Diseases of oesophagus, stomach and duodenum

947

2970

1.95

72.39

3.7

3.6

—

Other and unspecified iron deficiency

357

1269

2.86

72.36

4.2

3.6

—

Parasetamol

661

1486

2.28

72.15

3.4

3.6

—

Tumor necrosis factor alpha inhibitors

180

413

4.46

71.85

2.8

3.9

—

1007

2778

1.93

71.79

4.2

3.4

—

Bronchitis

946

3245

1.92

70.86

4.3

3.3

—

Extracorporeal dialysis

129

227

5.98

70.59

3.3

4.2

—

Noninfective enteritis and colitis

475

1966

2.44

70.44

3.6

3.8

—

Inflammatory bowel disease

342

1206

2.88

70.38

3.3

4.0

—

Preparatory care for dialysis

103

145

7.56

70.12

3.4

4.8

—

Other medical care

430

1664

2.56

69.95

4.3

3.9

—

Non-Hodgkin lymphoma, all

102

143

7.60

69.73

6.3

4.6

—

Failure and rejection of transplanted organs and tissues

15.31

69.54

15.6

2.7

—

Gastro-oesophageal reflux disease

639

2648

2.16

69.35

3.6

3.8

—

Crohn disease

173

397

4.46

69.08

3.0

4.4

—

Heart failure,strict

524

1602

2.39

68.93

4.4

3.7

—

Intestinal infectious diseases

840

3364

1.96

68.51

4.0

3.5

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

193

484

4.07

68.48

2.2

3.0

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

9.21

67.86

6.7

3.6

—

Multiple myeloma

10.04

67.60

4.2

4.7

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

10.04

67.60

4.2

4.7

—

Lung cancer and mesothelioma

210

471

3.88

66.83

2.7

3.5

—

Other disorders of teeth and supporting structures

246

741

3.38

66.53

4.6

3.6

—

Asthma, excluding more controls

536

1195

2.41

66.43

3.2

3.0

—

Nausea and vomiting

303

1014

2.98

66.33

3.7

3.8

—

Diarrhoea and gastroenteritis of presumed infectious origin

637

2757

2.12

66.29

3.5

—

Methotrexate

166

384

4.41

65.54

3.2

3.9

—

Hypothyroidism (congenital or acquired)

188

236

4.61

64.55

3.9

1.9

—

Other diseases of pleura

485

1856

2.35

64.14

4.4

3.8

—

Dyspnoea

792

3133

1.95

63.78

3.8

3.6

—

Rheumatoid arthritis, including avohilmo

396

1586

2.53

63.40

3.1

3.7

—

Other disorders of fluid, electrolyte and acid-base balance

335

1194

2.75

62.70

3.6

3.9

—

Follow-up examination after treatment for conditions other than malignant neoplasms

372

902

2.72

62.66

3.3

—

Other symptoms and signs involving the digestive system and abdomen

204

567

3.67

62.54

3.8

4.0

—

Asthma

549

1283

2.31

62.42

3.3

3.0

—

Other/unspecified seropositive rheumatoid arthritis

299

1058

2.87

61.32

3.2

4.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

296

1043

2.89

61.19

3.2

4.0

—

Leukaemia of unspecified cell type

31.45

61.15

8.7

4.4

—

Hypothyroidism, levothyroxine purchases

183

236

4.49

61.10

3.9

1.9

—

Hypothyroidism and >3 levothyroxin purchases

183

236

4.49

61.10

3.9

1.9

—

Seropositive rheumatoid arthritis, wide

301

1074

2.85

60.78

3.2

3.9

—

Chronic periodontitis

189

509

3.80

60.77

5.1

3.7

—

Early onset COPD, excluding more controls

201

564

3.62

60.57

3.2

—

Other disorders of skin and subcutaneous tissue

628

2825

2.05

60.50

4.1

3.6

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

531

2475

2.17

59.59

3.9

3.6

—

Osteoporosis

284

944

2.92

59.29

3.9

3.8

—

Abnormalities of breathing

783

2413

1.94

58.90

3.6

3.2

—

Acute upper respiratory infections of multiple and unspecified sites

636

2342

2.05

58.66

4.3

3.4

—

Metabolic disorders

826

2739

1.89

57.69

3.7

—

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

243

649

3.19

57.38

3.0

—

Gastrointestinal diseases

478

1009

2.39

57.35

4.1

2.9

—

Follow-up care involving plastic surgery

103

8.04

57.34

2.4

3.6

—

Other systemic involvement of connective tissue

295

1080

2.77

56.75

3.2

3.9

—

Symptoms and signs involving the urinary system

700

2795

1.95

56.60

3.7

3.8

—

DVT of lower extremities and pulmonary embolism

417

1797

2.34

56.37

4.4

3.8

—

Asthma (only as main-diagnosis), excluding more controls

466

1195

2.34

56.17

3.3

3.0

—

Substance use, excluding alcohol

208

628

3.37

56.10

2.3

4.0

—

Mental and behavioural disorders due to tobacco

127

272

4.82

55.50

2.3

4.4

—

Fentanyl

132

291

4.64

55.49

4.5

4.3

—

Glomerular disorders in diseases classified elsewhere

157

398

4.05

55.12

3.5

4.3

—

Infections of the skin and subcutaneous tissue

517

2453

2.12

54.85

3.9

3.6

—

Other soft tissue disorders, not elsewhere classified

782

2581

1.88

54.42

3.5

3.6

—

Smoking dependency

127

277

4.73

54.30

2.3

4.4

—

Persons encountering health services for examination and investigation

530

1206

2.22

53.91

4.2

3.4

—

Other (seronegative) rheumatoid arthritis, wide

219

704

3.17

53.39

3.3

4.0

—

Benzodiazepine use

840

3322

1.81

53.22

3.1

3.7

—

Drug-induced cataract

9.14

53.11

5.3

3.9

—

Malaise and fatigue

412

1491

2.32

53.08

3.6

3.3

—

Asthma (only as main-diagnosis)

476

1283

2.25

52.96

3.3

3.0

—

Diseases of the skin and subcutaneous tissue

863

2369

1.84

52.90

4.3

3.2

—

Other diseases of intestines

878

2842

1.81

52.86

3.7

3.5

—

Other viral diseases

280

1032

2.74

52.81

6.0

3.4

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

137

221

4.65

52.24

4.7

3.5

—

Crohn's disease NAS

104

199

5.40

51.83

2.9

4.2

—

Mycoses

272

1006

2.74

51.37

4.7

3.9

—

Chronic myeloproliferative disease

12.15

51.36

22.7

4.0

—

Asthma (mode)

516

1313

2.17

51.32

3.3

3.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

285

492

2.92

50.13

4.1

2.6

—

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

17.58

50.09

5.7

3.6

—

Acute myeloid leukaemia, helper endpoint

20.77

49.85

9.3

3.8

—

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

20.77

49.85

9.3

3.8

—

Other necrotizing vasculopathies (FG)

181

5.55

49.75

3.0

4.3

—

Glomerular diseases

212

698

3.09

49.67

3.7

4.2

—

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

27.20

49.35

12.7

3.1

—

Acute lymphocytic leukaemia, helper endpoint

27.20

49.35

12.7

3.1

—

ILD, hospital admission 2, with pulmonary infections

119

269

4.54

48.62

5.0

3.6

—

Heart failure, strict

552

1988

2.02

48.36

4.5

3.7

—

Cellulitis

224

775

2.93

48.00

4.1

3.9

—

Diseases of the respiratory system

496

1153

2.17

47.96

4.2

3.1

—

Ulcerative colitis, NAS

157

440

3.63

47.66

3.5

4.4

—

Depression medications

194

269

3.65

47.63

3.1

1.9

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

207

559

3.13

47.60

2.7

2.9

—

Unspecified urinary incontinence

119

275

4.45

47.33

3.0

3.9

—

Other problems related to primary support group, including family circumstances

142

365

3.87

46.81

4.5

3.3

—

Benign neoplasm: Colon

364

1204

2.34

46.75

3.9

3.0

—

Viral infections characterized by skin and mucous membrane lesions

377

1691

2.25

46.73

4.6

3.7

—

Anaemia in chronic diseases classified elsewhere

8.33

46.51

3.3

3.9

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

100

204

5.05

46.34

2.8

4.1

—

Venous thromboembolism

489

2359

2.03

46.27

4.4

3.6

—

Codeine or tramadol medication

929

3024

1.71

46.09

3.7

3.5

—

All-cause Heart Failure

540

1970

1.99

45.84

4.5

3.7

—

Certain disorders involving the immune mechanism

209

718

2.96

45.44

5.4

3.8

—

Benign neoplasm of colon, rectum, anus and anal canal

395

1272

2.24

45.11

3.9

3.0

—

Heart failure and antihypertensive medication

263

643

2.74

44.77

4.9

3.9

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

153

5.76

44.43

6.7

4.6

—

Other necrotizing vasculopathies

111

257

4.46

44.17

3.3

4.4

—

Acute upper respiratory infections

847

3102

1.72

44.06

4.0

3.5

—

Adalimumab

111

257

4.42

44.01

2.5

4.0

—

Leukaemia of unspecified cell type

14.66

43.44

8.7

4.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

357

981

2.32

43.39

4.2

3.4

—

Crohn disease (strict definition, require KELA)

193

5.01

43.26

2.9

4.0

—

Benign neoplasms

517

1456

2.02

43.26

3.9

2.7

—

Other/unspecified rheumatoid arthritis

154

455

3.46

43.25

3.6

4.0

—

Later onset COPD, excluding more controls

194

494

3.11

43.22

3.1

3.5

—

Cytomegalovirus infection, IBD co-morbidity

8.59

43.19

10.8

3.6

—

Ulcerative colitis

238

900

2.68

43.09

3.4

4.1

—

Disorders of lens

584

1938

1.91

43.03

4.2

3.7

—

L01XE Protein kinase inhibitors

100

218

4.78

43.02

13.6

4.0

—

Diseases of oral cavity, salivary glands and jaws

768

2228

1.78

42.80

4.4

3.4

—

Examination and observation for other reasons

419

1183

2.17

42.76

3.6

3.4

—

Chronic laryngitis and laryngotracheitis

163

503

3.30

42.67

2.8

4.2

—

Diseases of liver

320

1396

2.32

42.58

3.3

3.8

—

Crohn disease (strict definition, require KELA, min 2 HDR)

193

4.96

42.28

2.8

4.0

—

Cytomegaloviral disease

8.32

42.18

10.8

3.3

—

Iron deficiency anaemia secondary to blood loss (chronic)

177

578

3.12

42.13

5.2

4.0

—

Symptoms and signs involving the skin and subcutaneous tissue

563

3018

1.87

42.11

4.6

3.5

—

Sleep disorders (combined)

789

3039

1.71

40.74

3.3

3.7

—

Other functional intestinal disorders

399

1836

2.09

40.69

3.8

3.6

—

Gout

270

1012

2.46

40.35

4.2

—

Disorders of gallbladder, biliary tract and pancreas

795

3024

1.70

40.27

3.8

3.7

—

Polyneuropathies and other disorders of the peripheral nervous system

228

875

2.65

40.22

5.1

4.1

—

Ulcer of lower limb, not elsewhere classified

161

512

3.21

40.16

3.6

4.2

—

Orthopaedic devices associated with adverse incidents

9.09

40.06

2.2

3.9

—

Pulmonary embolism

277

1167

2.40

39.96

4.5

3.9

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

279

989

2.43

39.92

3.5

4.0

—

Pulmonary heart disease

277

1169

2.40

39.81

4.5

3.9

—

Cardiovascular diseases (excluding rheumatic etc)

468

1341

2.03

39.79

3.8

3.1

—

Pulmonary heart disease, diseases of pulmonary circulation

299

1307

2.31

39.63

4.6

3.8

—

Seronegative rheumatoid arthritis

128

357

3.65

39.24

3.1

4.2

—

Crohn's disease of small intestine

194

4.76

39.08

2.5

4.5

—

Kidney transplant status

195

4.79

39.01

4.3

4.4

—

Other reaction to severe stress, and adjustment disorders

286

1236

2.33

38.86

4.2

3.5

—

Persons encountering health services in other circumstances

337

1561

2.18

38.67

3.2

3.6

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

151

442

3.27

38.53

2.6

3.0

—

Non-invasive ventilation

197

669

2.80

38.42

4.0

3.9

—

Other/unspecified cytomegaloviral diseases

8.16

38.32

11.4

3.8

—

Dialysis

141

5.55

38.32

4.5

4.8

—

ILD, hospital admissions 3, with pneumonia sepsis

103

251

4.21

38.30

5.3

3.6

—

Acute lymphocytic leukaemia

15.62

38.19

12.7

4.5

—

Other disorders of lacrimal gland

305

1367

2.26

38.12

4.3

3.7

—

Other specific joint derangements/joint disorders

553

2005

1.86

38.00

3.2

3.6

—

Other disorders of urethra and urinary system

561

2302

1.84

37.94

4.0

3.5

—

Essential (haemorrhagic) thrombocythaemia

7.35

37.92

7.4

2.8

—

COPD, hospital admission 2, with asthma infections

316

1214

2.25

37.88

3.3

4.1

—

Acute sinusitis

392

1802

2.04

37.68

4.8

3.3

—

Obesity due to excess calories

370

1798

2.07

37.55

2.8

3.7

—

Other chronic obstructive pulmonary disease

417

1740

2.01

37.50

3.2

3.9

—

Factors influencing health status and contact with health services

252

481

2.65

37.34

4.8

3.2

—

Follicular lymphoma

6.68

37.24

4.8

2.9

—

Unspecified kidney failure

121

338

3.66

37.12

4.3

3.7

—

Zoster [herpes zoster]

186

671

2.82

37.07

5.3

4.1

—

Acute myeloid leukaemia

12.06

37.07

9.3

4.1

—

Chronic periodontitis, complicated

118

325

3.72

36.98

5.6

4.2

—

Hypertensive diseases (excluding secondary)

387

1069

2.12

36.97

3.8

3.3

—

Sleep apnoea

727

2918

1.70

36.95

3.3

3.8

—

Other diseases of hard tissues of teeth

499

1979

1.89

36.93

4.0

3.4

—

Exposure to other specified factors

579

3065

1.78

36.85

3.8

3.5

—

Other acute lower respiratory infections

455

2283

1.92

36.55

4.5

3.5

—

COPD

426

1792

1.98

36.55

3.2

3.9

—

All influenza (not pneumonia)

139

428

3.29

36.49

5.6

3.7

—

Other dialysis

109

6.19

36.39

4.0

4.4

—

Dermatitis and eczema

857

3477

1.62

36.39

4.0

3.5

—

Constipation

718

3055

1.69

36.37

3.4

3.8

—

Non-ischemic cardiomyopathy

308

1144

2.24

36.27

4.9

3.7

—

Other noninfective gastroenteritis and colitis

230

932

2.50

36.14

4.0

4.1

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

157

523

3.05

36.13

3.5

3.9

—

Ulcerative colitis (strict definition, require KELA)

162

550

2.99

36.05

3.5

3.9

—

SLE (Finngen)

6.91

35.86

3.5

3.8

—

Pain in limb

606

2494

1.77

35.85

3.6

3.7

—

COPD, hospital admissions

419

1817

1.97

35.67

3.2

4.0

—

Crohn disease (strict definition, all UC cases excluded)

150

5.15

35.66

2.8

3.9

—

Acquired haemolytic anaemia

7.38

35.54

7.1

4.2

—

Other diseases of urinary system

820

2819

1.64

35.49

3.6

3.5

—

Cardiovascular diseases

436

1192

2.00

35.48

3.7

3.1

—

Other heart diseases

358

1123

2.12

35.43

4.1

3.3

—

Gout, FINNGEN

270

1187

2.30

35.42

4.2

4.0

—

Myelodysplastic syndrome

12.28

35.35

15.2

4.2

—

Acute bronchitis

360

1734

2.05

35.33

4.3

3.6

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

170

600

2.87

35.26

3.5

3.8

—

COPD, early/later onset

421

1834

1.96

35.11

3.2

4.0

—

Disorders of other endocrine glands

368

1799

2.03

35.08

3.7

3.6

—

Presence of other devices

214

857

2.53

34.54

3.7

3.5

—

Localized swelling, mass and lump of skin and subcutaneous tissue

280

1264

2.24

34.45

4.3

3.6

—

Disorders of lacrimal system

349

1715

2.05

34.45

4.0

3.7

—

Asthma-related pneumonia

330

1587

2.10

34.41

3.6

3.9

—

Fungal Sepsis

101

6.17

34.40

6.6

5.1

—

Asthma, hospital admissions 3, pneumonia

331

1595

2.09

34.33

3.6

3.9

—

Asthma-related pneumonia or sepsis

331

1595

2.09

34.33

3.6

3.9

—

Headache

426

1856

1.93

34.27

3.6

3.0

—

Other and unspecified polyneuropathies, also in other diseases

195

754

2.63

33.99

4.9

4.0

—

Fall on same level

900

3182

1.59

33.76

3.6

—

Diseases of the ear and mastoid process

896

2859

1.59

33.37

3.8

3.5

—

Dermatitis

480

2654

1.82

33.19

4.1

3.5

—

Crohn's disease of large intestine

152

4.94

33.13

3.4

4.0

—

Substance abuse, excluding more controls

455

2154

1.86

33.03

2.5

3.8

—

Other and unspecified dermatitis

408

2151

1.91

32.85

4.3

3.5

—

Neurological diseases, wide definition

231

452

2.58

32.76

3.4

3.0

—

Immunodeficiency with predominantly antibody defects

6.70

32.71

6.4

3.6

—

Symptoms and signs involving the digestive system and abdomen

810

2513

1.62

32.45

3.7

3.6

—

Other arthritis (FG)

251

1111

2.28

32.39

3.9

3.8

—

Senile cataract

516

1780

1.81

32.04

4.1

3.8

—

Other chronic obstructive pulmonary disease, including avohilmo

466

2129

1.84

32.02

3.2

3.9

—

Other heart diseases, wide

688

2578

1.66

31.87

3.9

3.5

—

Undetermined asthma, excluding more controls

104

290

3.63

31.86

3.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

748

3017

1.62

31.71

4.1

3.6

—

Cerebrovascular diseases (FINNGEN)

250

776

2.32

31.47

3.8

3.5

—

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

11.78

31.45

8.5

3.5

—

Pain in joint

461

1656

1.85

31.41

3.3

3.6

—

Gonarthrosis [arthrosis of knee](FG)

566

1910

1.75

31.35

3.4

3.9

—

Bleeding

665

2936

1.66

31.26

4.5

3.6

—

Disorders of mineral metabolism

101

282

3.67

31.09

4.0

4.1

—

Disorders of eyelid, lacrimal system and orbit

659

3146

1.65

31.06

4.0

3.6

—

Other nutritional deficiencies

470

2577

1.79

30.88

2.9

3.6

—

Hypothyroidism, drug reimbursement

144

4.35

30.78

3.2

1.9

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

115

352

3.34

30.71

9.4

3.7

—

Other Crohn's disease

199

4.21

30.70

2.8

4.2

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

214

610

2.48

30.69

3.4

3.7

—

Dental operations

535

1543

1.79

30.68

4.2

3.4

—

Disorders resulting from impaired renal tubular function

132

5.14

30.54

3.5

4.2

—

Candidiasis

134

450

3.03

30.53

3.3

3.8

—

Type 2 diabetes, wide definition

636

2493

1.67

30.34

3.7

3.9

—

Disorders of calcium metabolism

210

4.11

30.30

3.7

4.5

—

Sleep apnoea, including avohilmo

735

2978

1.61

30.20

3.3

3.8

—

Hypothyroidism, strict autoimmune

508

1904

1.77

30.15

3.2

3.6

—

Moderate visual impairment, binocular

104

5.72

30.14

3.1

4.1

—

therapeutic use

6.01

30.01

2.3

4.5

—

COPD related to multimorbidity

353

1527

1.96

29.92

3.2

4.1

—

Systemic lupus erythematosus

101

5.74

29.91

3.5

3.3

—

Diseases of external ear

286

1378

2.10

29.89

3.1

3.9

—

Haemolytic anaemias

112

5.48

29.87

6.7

4.2

—

Undetermined asthma

104

303

3.47

29.84

3.3

—

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

10.31

29.73

6.8

3.7

—

Direct fill therapy

138

480

2.92

29.53

5.3

4.1

—

Dentofacial anomalies [including malocclusion]

208

875

2.37

29.42

4.0

3.2

—

Soft tissue disorders

797

2628

1.58

29.14

3.7

3.6

—

Hypo-osmolality and hyponatraemia

167

644

2.62

29.12

3.7

4.3

—

Other autoimmune haemolytic anaemias

8.82

29.09

5.6

3.4

—

Hypertension, essential

563

1876

1.72

29.08

3.8

3.6

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

209

886

2.35

29.05

4.7

3.3

—

DVT of lower extremities

183

741

2.50

29.02

4.2

3.9

—

Pneumonia due to other infectious organisms, not elsewhere classified

6.35

28.97

12.8

3.3

—

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

174

4.35

28.91

2.7

3.1

—

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

119

5.19

28.85

5.6

3.2

—

SLE, strict definition

101

5.64

28.84

3.6

3.4

—

SLE, ICD10

101

5.64

28.84

3.6

3.4

—

Symptoms and signs involving the circulatory and respiratory systems

767

2423

1.59

28.68

4.3

3.3

—

Obesity

444

2483

1.78

28.66

2.7

3.6

—

Hypokalaemia

120

393

3.11

28.61

3.4

4.8

—

Urticaria and erythema

288

1415

2.05

28.54

4.5

3.7

—

Obesity and other hyperalimentation

445

2492

1.78

28.52

2.7

3.6

—

Mantle cell lymphoma

10.52

28.50

6.2

4.3

—

Other pleural conditions

119

391

3.10

28.27

5.9

3.8

—

Disorders of tooth development and eruption

128

4.90

28.26

5.3

3.3

—

Symptoms and signs concerning food and fluid intake

290

3.46

28.23

3.2

—

Polyarthrosis

176

678

2.52

28.12

2.6

3.8

—

Myalgia

189

788

2.42

28.09

2.9

3.7

—

Polymyalgia rheumatica

137

490

2.84

27.93

3.3

4.6

—

Other disorders of ear

703

2956

1.59

27.83

3.6

3.7

—

Implicit fungal Sepsis

5.73

27.73

7.1

4.9

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

300

1160

2.03

27.68

2.7

3.0

—

Parodontitis

675

3130

1.60

27.60

3.7

—

Parodontitis or operation codes

675

3131

1.60

27.47

3.7

—

Substance abuse

455

2503

1.75

27.36

2.5

3.9

—

Other abnormal uterine and vaginal bleeding

198

589

2.42

27.31

3.6

3.2

—

Other diseases of blood and blood-forming organs

222

3.83

27.27

6.8

3.6

—

Other viral diseases, not elsewhere classified

166

660

2.54

27.20

5.7

3.7

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

249

1186

2.12

26.88

3.9

4.0

—

Other specified/unspecified arthritis

214

960

2.25

26.86

4.0

3.8

—

Use of hypnotics and sedatives

805

3036

1.54

26.85

3.5

3.6

—

Conductive and sensorineural hearing loss

618

2651

1.62

26.67

3.6

3.8

—

Gout, unspecified

193

833

2.35

26.65

4.4

4.0

—

Chronic periodontitis, including avohilmo

668

3133

1.58

26.50

3.6

3.7

—

Mental and behavioural disorders due to psychoactive substance use

462

2543

1.72

26.46

2.5

3.9

—

Pleural effusion

154

602

2.60

26.39

4.3

3.7

—

Any operation in hilmo

15.42

26.38

2.8

1.2

—

Missing teeth due to accident, extraction or parodontitis

113

375

3.06

26.36

5.8

3.9

—

Neurological diseases

669

2098

1.61

26.34

3.7

3.6

—

Genitourinary diseases

463

1308

1.78

26.26

4.1

3.5

—

Seropositive rheumatoid arthritis, strict definition

147

564

2.64

26.15

2.9

3.9

—

Syncope and collapse

316

1455

1.94

26.15

3.7

3.3

—

Chronic gastritis

240

1140

2.13

26.13

4.5

3.8

—

Sensorineural hearing loss

594

2569

1.63

25.97

3.5

3.8

—

Viral pneumonia (unknown virus, not influenza)

216

3.79

25.93

5.2

4.3

—

Malignant immunoproliferative diseases

12.78

25.92

9.3

4.4

—

Diagnoses used for exclusion with ILD

225

1046

2.17

25.91

4.4

4.0

—

Asthma, hospital admission 2, infections

454

2624

1.71

25.52

3.3

3.6

—

Asthma-related infections

454

2624

1.71

25.52

3.3

3.6

—

Heart failure and bmi 25plus

359

1335

1.87

25.42

4.3

3.4

—

Cough

325

1660

1.89

25.40

4.3

3.3

—

Arthropathies in other diseases classified elsewhere

102

5.26

25.37

4.1

—

Hypertensive diseases

568

1954

1.65

25.34

3.9

3.7

—

Hypertension

567

1950

1.65

25.30

3.9

3.7

—

Type of accident

232

1102

2.12

25.27

3.8

4.0

—

Polycystic ovarian syndrome, consortium definition

455

1578

1.75

25.24

3.3

3.2

—

Parodontitis and operation codes

630

3106

1.58

25.19

3.7

—

Diverticular disease of intestine

530

2125

1.67

25.15

4.1

3.6

—

Hodgkin lymphoma

7.33

25.13

4.7

3.5

—

COPD, hospital admissions 1, only main diagnosis

311

1389

1.92

24.99

3.2

3.9

—

Early onset COPD

201

909

2.24

24.84

3.2

4.0

—

Abdominal and pelvic pain

765

2511

1.54

24.67

3.6

—

Glucagon-like peptide-1 (GLP-1) analogues

461

2243

1.70

24.65

3.0

4.0

—

Persons encountering health services in other circumstances, wide

915

3227

1.48

24.57

3.6

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

195

876

2.25

24.50

3.6

—

Malignant neoplasm of respiratory system and intrathoracic organs

205

862

2.21

24.34

3.1

3.9

—

Systemic lupus erythematosus, unspecified

5.53

24.17

3.4

3.6

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

124

455

2.76

24.09

3.7

4.0

—

Convulsions, not elsewhere classified

167

697

2.38

24.06

3.6

3.2

—

Pyogenic arthritis

195

3.82

24.03

2.9

4.2

—

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

5.35

24.00

2.4

3.4

—

Arthropathies

660

2136

1.58

23.97

3.6

3.7

—

Other respiratory diseases principally affecting the interstitium

168

718

2.37

23.78

4.7

4.1

—

Familial hypercholesterolemia

156

645

2.45

23.78

3.6

4.3

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

263

847

2.04

23.77

2.5

2.8

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

263

847

2.04

23.77

2.5

2.8

—

Other joint disorders

627

2110

1.59

23.66

3.3

3.6

—

Acute pharyngitis

117

417

2.82

23.64

4.3

3.3

—

Cutaneous abscess, furuncle and carbuncle

198

908

2.20

23.63

3.5

3.9

—

Intestinal stricture

257

1301

1.99

23.59

3.5

4.0

—

Disorders of thyroid, IBD co-morbidities

122

314

2.85

23.50

3.6

3.2

—

Immunodeficiencies

176

3.97

23.50

5.7

3.7

—

Stomatitis and related lesions

226

3.55

23.49

7.4

3.7

—

Paralytic ileus and intestinal obstruction

213

1009

2.13

23.40

3.7

3.8

—

Benign neoplasm: Colon, unspecified

168

719

2.35

23.35

3.9

2.9

—

Diseases of the digestive system

373

2128

1.76

23.26

3.9

3.7

—

Falls/tendency to fall

820

2758

1.49

23.19

3.5

3.6

—

Mucosal proctocolitis

109

383

2.88

22.99

3.1

4.2

—

ILD, hospital admissions

147

602

2.48

22.93

4.9

4.1

—

Drug-induced osteoporosis

9.91

22.88

4.4

3.5

—

Visual impairment including blindness (binocular or monocular)

245

3.42

22.88

3.1

4.1

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

290

3.19

22.83

5.7

3.5

—

Osteoporosis with pathological fracture (FG)

198

3.71

22.77

3.0

4.0

—

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

162

4.03

22.75

2.2

3.3

—

Gout, idiopatic and unspecified

218

1055

2.09

22.73

4.3

4.0

—

Other antidepressants

768

2672

1.51

22.72

2.9

3.8

—

Psychiatric diseases

826

2795

1.49

22.72

3.3

3.7

—

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

11.72

22.70

10.9

3.0

—

Interstitial lung disease

148

611

2.46

22.68

4.9

4.1

—

Interstitial lung disease endpoints

148

611

2.46

22.68

4.9

4.1

—

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

171

3.93

22.67

3.7

3.0

—

Idiopathic thrombocytopenic purpura

101

5.03

22.66

6.2

3.8

—

Special screening examination for infectious and parasitic diseases

144

425

2.55

22.57

2.1

3.3

—

Other and unspecified aplastic anaemias

8.86

22.54

6.0

4.1

—

Other interstitial pulmonary diseases

148

613

2.45

22.53

4.9

4.1

—

Other cataract

335

1433

1.82

22.50

4.0

3.8

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

137

550

2.53

22.30

3.9

4.4

—

Hypoplasia of dental enamel, including avohilmo

7.23

22.28

6.3

4.2

—

Endocrine, nutritional and metabolic diseases

585

1873

1.59

22.26

3.7

3.6

—

Chronic ulcer of skin, not elsewhere classified

240

3.41

22.19

5.6

3.7

—

External causes of morbidity and mortality

487

1466

1.67

22.15

3.7

3.4

—

Anxiety disorders, excluding more controls

575

2428

1.58

22.02

3.6

—

In situ neoplasms

221

1033

2.05

22.00

4.7

2.8

—

FESS (DNB20)

111

405

2.78

21.87

3.5

4.1

—

Dermatitis due to substances taken internally

176

3.83

21.84

4.4

—

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

108

4.72

21.77

3.9

3.1

—

Other respiratory disorders and diseases

184

850

2.19

21.66

3.8

4.2

—

Other diseases of the respiratory system

184

850

2.19

21.66

3.8

4.2

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

345

1320

1.79

21.59

4.5

2.9

—

Presence of other functional implants

435

1848

1.68

21.53

3.4

—

Diseases of the musculoskeletal system and connective tissue

396

1136

1.76

21.51

3.8

3.4

—

Other external causes of accidental injury

625

2017

1.56

21.47

4.0

3.6

—

Fibrosis and cirrhosis of liver

266

3.23

21.38

3.6

4.0

—

Phlebitis and thrombophlebitis (not including DVT)

185

861

2.17

21.36

3.5

3.7

—

Neurotic, stress-related and somatoform disorders

606

2805

1.54

21.34

3.5

3.6

—

Antihypertensive medication - note that there are other indications

407

1295

1.73

21.30

3.6

3.3

—

Urticaria

222

1107

2.02

21.29

5.0

3.7

—

Noninfectious colitis NAS

121

468

2.62

21.27

3.9

4.3

—

Atrial fibrillation and flutter

230

735

2.06

21.26

3.6

—

Cholangitis (primary sclerosing, PSC)

213

3.50

21.17

3.5

4.0

—

Non-small cell lung cancer

151

650

2.35

21.10

2.6

4.2

—

Diseases of the myoneural junction and muscle

116

442

2.66

21.05

3.7

4.1

—

Follicular lymphoma, hilmo

154

4.02

21.03

4.8

4.4

—

Cholelithiasis, broad definition with cholecystitis

625

2815

1.53

20.98

3.9

3.7

—

Coxarthrosis [arthrosis of hip](FG)

389

1652

1.71

20.94

3.9

—

L04AC Interleukin inhibitors

133

4.23

20.82

2.5

3.8

—

Generalized skin eruption due to drugs and medicaments

142

4.14

20.80

4.0

3.6

—

Other diseases of the digestive system

263

1402

1.89

20.76

4.0

—

Episodal and paroxysmal disorders

822

2901

1.46

20.70

3.3

3.7

—

Collagenous colitis

297

3.05

20.70

3.9

4.2

—

Other diseases of lip and oral mucosa

134

552

2.46

20.63

4.6

3.9

—

Nerve, nerve root and plexus disorders

758

3257

1.47

20.62

3.5

3.7

—

Malignant neoplasm of bronchus and lung

173

743

2.20

20.47

2.7

4.1

—

Gingivitis and periodontal diseases

644

2185

1.53

20.42

4.0

3.4

—

Accidents

619

2017

1.54

20.41

4.0

3.6

—

Hydronephrosis

101

364

2.81

20.41

2.8

3.8

—

Mature T/NK-cell lymphomas, hilmo

6.76

20.37

8.5

3.8

—

Drug-induced osteoporosis with pathological fracture

6.72

20.34

3.2

3.6

—

Spondylopathies

588

2322

1.54

20.29

3.6

3.7

—

Gastroduodenal ulcer

217

1091

2.00

20.24

3.2

3.9

—

Gonarthrosis

471

1663

1.63

20.24

3.4

3.9

—

Pneumocystosis

6.28

20.22

14.9

3.8

—

Cystitis

609

2443

1.53

20.17

3.4

3.5

—

Convalescence

145

4.01

20.16

2.8

4.2

—

Pure hypercholesterolaemia

539

2321

1.57

20.10

3.6

3.8

—

Exposure to unspecified factor

691

3647

1.48

20.07

3.1

3.7

—

Vocal cord dysfunction

328

2.83

20.01

2.9

3.7

—

Unspecified haematuria

332

1634

1.75

19.98

4.2

3.8

—

Anxiety disorders

607

2844

1.52

19.97

3.5

—

Dental caries 3 and operation codes

675

2313

1.50

19.85

3.6

3.7

—

Exclusions for E4_PCOS_BROAD

143

618

2.34

19.77

4.4

4.0

—

Ethmoidectomy

111

427

2.63

19.76

3.5

4.0

—

Dental caries 1 and operation codes

650

2212

1.51

19.74

4.0

3.6

—

Mixed connective tissue disease

213

3.40

19.73

2.6

3.8

—

Presence of cardiac and vascular implants and grafts

350

1547

1.72

19.46

3.0

3.5

—

Molar incisor enamel hypoplasia, with caries

7.60

19.41

7.6

2.7

—

Other benign neoplasms of skin

223

1129

1.95

19.35

4.0

2.9

—

COPD-related respiratory insufficiency

115

456

2.56

19.30

4.2

4.3

—

Acute suppurative otitis media

178

789

2.12

19.29

3.7

3.2

—

Other disorders of gingiva or/and edentulous alveolar ridge

146

3.92

19.17

3.3

3.5

—

Other specified/unspecified systemic involvement of connective tissue

183

3.57

19.16

2.7

3.9

—

Impacted cerumen

101

377

2.73

19.16

2.7

4.1

—

Gout, strict definition

161

743

2.19

19.10

4.5

4.0

—

Sicca syndrome [Sjögren]

279

3.02

19.09

3.0

3.6

—

Valvular heart disease excluding rheumatic fever

365

1584

1.69

18.96

4.0

3.9

—

Chronic lower respiratory diseases

871

3343

1.41

18.94

3.3

3.7

—

Other diseases of anus and rectum

228

1198

1.92

18.81

4.2

3.9

—

Inflammatory diseases of female pelvic organs

371

1676

1.68

18.70

2.9

3.3

—

Acute generalized exanthematous pustulosis

163

3.71

18.65

4.1

3.9

—

Pain (limb, back, neck, head abdominally)

560

1823

1.54

18.63

3.9

3.6

—

Non-rheumatic valve diseases

360

1564

1.69

18.56

4.0

3.9

—

Diseases of peritoneum

366

2.72

18.56

3.2

3.9

—

Any mental disorder

820

2886

1.43

18.52

3.3

3.7

—

Respiratory insufficiency

206

3.34

18.51

3.2

3.5

—

Insulin medication

456

2481

1.58

18.47

3.7

3.9

—

GI-bleeding

256

1406

1.83

18.45

4.0

—

Amputation

102

390

2.66

18.44

3.3

4.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

797

3198

1.43

18.36

3.8

3.6

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

189

753

2.05

18.27

2.2

2.9

—

Other diseases of jaws

184

3.48

18.24

3.1

3.9

—

Diseases of spleen

5.96

18.24

6.8

3.9

—

Acquired absence of limb

9.09

18.23

3.4

4.6

—

Disorders of lipoprotein metabolism and other lipidaemias

584

2447

1.51

18.17

3.5

3.7

—

Respiratory disorders in diseases classified elsewhere

6.80

18.13

4.3

3.3

—

ILD, hospital admissions 1, main diag only

126

537

2.38

18.11

4.7

4.1

—

Cholelithiasis

588

2766

1.50

18.09

3.9

3.7

—

Low back pain

505

2535

1.54

18.07

3.4

3.6

—

MS-disease / Multiple Sclerosis

200

3.35

18.05

3.1

3.6

—

Infections with a predominantly sexual mode of transmission

185

920

2.02

17.91

3.0

3.4

—

Suppurative and unspecified otitis media

239

1142

1.87

17.90

3.7

3.3

—

Volume depletion

329

2.78

17.78

3.2

4.7

—

Other and unspecified urticaria

151

699

2.18

17.77

4.5

4.1

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

313

2.83

17.75

3.3

3.8

—

Polyarteritis nodosa and related conditions

6.62

17.74

4.7

3.2

—

Cardiac arrhythmias

398

1618

1.63

17.73

3.7

—

Mood disorders, excluding more controls

651

2711

1.47

17.66

3.3

3.7

—

Hepatic failure, not elsewhere classified

128

4.02

17.64

4.3

4.5

—

Psoriasis

214

1127

1.91

17.63

3.3

3.9

—

Spondyloarthritis

133

586

2.29

17.63

2.5

4.2

—

Secondary thrombocytopenia

7.43

17.58

4.2

3.2

—

Type 2 diabetes

687

2822

1.45

17.54

3.3

3.8

—

Infliximab

9.77

17.53

2.3

2.8

—

Eosinophilic disease (BM)

7.65

17.51

5.4

3.9

—

Internal derangement of knee

256

1425

1.80

17.49

3.3

3.9

—

Sarcoidosis

114

472

2.44

17.46

4.2

3.9

—

Obesity related asthma

249

1380

1.82

17.46

3.0

4.0

—

Protozoal diseases

4.58

17.44

13.8

3.9

—

Psoriasis vulgaris

150

699

2.17

17.38

3.5

4.1

—

Exclusions for E4_PCOS_CONSORTIUM

464

1861

1.57

17.38

3.9

3.3

—

Speech therapy

1167

0.19

17.38

4.0

—

Benign neoplasms

695

2690

1.45

17.34

3.9

3.4

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

169

824

2.06

17.33

2.7

3.6

—

Spondylopathies (FG)

103

408

2.55

17.31

2.3

4.0

—

Poisoning by drugs, medicaments and biological substances

161

772

2.10

17.29

3.0

3.8

—

Paracetamol of NSAID medication

138

291

2.40

17.28

4.1

3.6

—

Gastric ulcer

149

695

2.17

17.23

3.5

4.0

—

Injuries to the ankle and foot

451

2656

1.55

17.22

3.5

—

Nonhereditary hypogammaglobulinemia

7.28

17.19

6.7

3.5

—

Other or unspecified ileus, impaction or obstruction

146

676

2.18

17.17

3.6

4.1

—

Misadventures to patients during surgical and medical care

114

476

2.42

17.15

3.6

—

Insulin, combination of fast acting with intermediate-acting or long-acting

456

2733

1.55

17.04

3.7

—

All anxiety disorders

377

1879

1.62

16.98

3.0

3.5

—

Other and unspecified drugs and medicaments

282

2.88

16.95

4.8

3.9

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

295

1170

1.74

16.92

4.7

2.9

—

Other disorders of kidney and ureter

111

461

2.44

16.92

4.4

4.1

—

Anxiety (asthma-related co-morbidities)

371

1805

1.63

16.89

3.0

3.5

—

Diseases of arteries, arterioles and capillaries

496

2439

1.52

16.86

3.7

3.8

—

Other diseases of biliary tract

294

2.83

16.84

2.9

4.0

—

Dysphagia

185

944

1.98

16.77

3.6

3.9

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

7.79

16.76

10.9

3.5

—

Suppurative and necrotic conditions of lower respiratory tract

195

3.30

16.74

3.4

4.3

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

213

674

1.94

16.71

4.0

3.0

—

Coxarthrosis

360

1490

1.65

16.70

3.9

—

Hypothyroidism, other/unspecified

617

2799

1.46

16.68

3.5

3.6

—

Diseases of middle ear and mastoid

380

1942

1.61

16.66

4.1

3.4

—

Disorders of parathyroid gland

165

800

2.06

16.64

3.7

—

Unspecified fall

358

2202

1.62

16.62

3.4

3.7

—

Pain, not elsewhere classified

167

825

2.04

16.56

3.7

3.3

—

Pneumonia due to Streptococcus pneumoniae

116

4.05

16.52

3.3

—

313

1864

1.67

16.50

3.5

3.8

—

Dental caries, including avohilmo

588

2031

1.49

16.47

4.0

3.7

—

Disorders of the thyroid gland

661

3016

1.44

16.42

3.6

—

Dental caries 1

588

2033

1.48

16.38

4.0

3.7

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

289

1154

1.74

16.37

4.7

2.9

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

634

2902

1.45

16.35

3.5

3.6

—

Other female pelvic inflammatory diseases

121

530

2.31

16.33

3.6

—

Conjunctivitis (acute, non atopic)

206

1096

1.89

16.31

3.4

3.7

—

Arthrosis

488

1752

1.54

16.30

3.6

3.8

—

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

6.72

16.30

4.0

4.5

—

Problems related to lifestyle

299

2.77

16.29

2.8

4.1

—

Leisure time condition

137

633

2.19

16.25

3.5

4.3

—

Haemorrhage from respiratory passages

264

1407

1.75

16.23

5.0

3.4

—

Retention of urine

262

1265

1.76

16.20

3.3

3.8

—

Diabetes mellitus

709

2991

1.42

16.17

3.3

3.7

—

Shoulder lesions

537

2208

1.49

16.11

3.5

3.8

—

Other complications of surgical and medical care, not elsewhere classified

318

2.71

16.10

4.7

3.6

—

Malignant immunoproliferative diseases

6.82

16.09

9.3

4.4

—

Lung transplant status

7.81

15.95

11.3

4.1

—

Lung transplantation

7.81

15.95

11.3

4.1

—

Benign neoplasm: Sigmoid colon

118

517

2.30

15.92

3.7

3.1

—

Diabetes, varying definitions

706

2989

1.42

15.91

3.4

3.7

—

Injuries to the knee and lower leg

824

3430

1.38

15.81

3.3

3.6

—

Type 2 diabetes, definitions combined

656

2741

1.43

15.79

3.2

3.8

—

Psoriatic and enteropathic arthropathies

350

2.60

15.77

2.3

4.2

—

Diabetes, insulin treatment (Kela reimbursement)

709

3084

1.41

15.73

3.2

3.8

—

Pain in throat and chest

556

2309

1.48

15.73

4.0

3.3

—

Coxibs

220

620

1.90

15.70

3.0

4.7

—

STROKE

425

1904

1.56

15.70

3.8

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

673

2899

1.42

15.64

3.2

3.8

—

Epilepsy

232

1301

1.79

15.54

3.5

4.0

—

Bacterial pneumoniae

254

1292

1.75

15.48

3.5

3.3

—

Gonarthrosis,primary

641

2828

1.43

15.46

3.3

3.8

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

10.15

15.41

10.7

3.9

—

Type 2 diabetes, strict (exclude DM1)

658

2767

1.42

15.35

3.2

3.8

—

Fibromyalgia

221

3.02

15.33

2.4

4.0

—

Diseases of the eye and adnexa

559

1899

1.48

15.32

4.1

3.2

—

Insulin, intermediate and long-acting

397

2523

1.55

15.27

3.4

3.8

—

Wegener granulomatosis

5.84

15.22

3.1

4.0

—

Disorders of optic nerve and visual pathways

316

2.66

15.22

4.3

3.9

—

Disorders of choroid and retina

574

2896

1.45

15.20

3.9

3.8

—

Benign neoplasm of other and unspecified endocrine glands

322

2.64

15.16

4.7

3.0

—

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

5.74

15.15

1.9

3.8

—

Microscopic polyangiitis

10.89

15.14

2.9

3.9

—

Dental pulpitis 2

524

1806

1.49

15.02

4.1

3.7

—

Acute peritonitis

235

2.95

15.01

3.3

4.0

—

Temporomandibular joint disorders

113

499

2.28

14.99

3.2

3.8

—

Other skin changes

135

643

2.12

14.88

5.8

3.9

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

111

488

2.29

14.88

2.9

3.6

—

Other follicular disorders

215

3.02

14.82

4.9

4.4

—

Ulcerative enterocolitis

4.40

14.82

3.9

4.1

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

112

486

2.28

14.82

2.3

2.9

—

Other and unspecified myopathies

315

2.64

14.80

4.3

3.9

—

Juvenile arthritis (FINNGEN)

126

3.71

14.73

2.6

4.4

—

Polyuria

167

862

1.95

14.73

3.9

4.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

563

2663

1.45

14.67

3.3

3.5

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

368

2.49

14.65

3.8

3.0

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

8.69

14.64

3.5

—

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

141

3.53

14.58

2.8

3.2

—

Inflammatory diseases of the central nervous system

283

2.72

14.58

3.9

4.3

—

Recurring oral aphthae, including avohilmo

112

500

2.27

14.53

5.8

3.9

—

Nonsuppurative otitis media

159

695

1.99

14.47

4.3

3.3

—

Other local infections of skin and subcutaneous tissue

342

2.55

14.45

3.6

4.1

—

Other diseases of liver

131

624

2.12

14.44

2.8

3.8

—

Excessive, frequent and irregular menstruation

250

791

1.77

14.43

3.4

3.0

—

Pneumonia derived septicemia

119

3.79

14.42

3.5

4.0

—

Injuries to the head

755

3596

1.37

14.40

3.5

3.6

—

Menorrhagia

232

715

1.80

14.32

3.0

3.1

—

Depression

628

3074

1.41

14.31

3.2

3.6

—

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

4.58

14.30

2.3

3.4

—

Papulosquamous disorders

279

1692

1.66

14.27

3.3

3.8

—

Psoriasis (vulgaris), strict definition

4.19

14.27

2.4

4.2

—

Viral pneumonia (known virus, not influenza)

4.38

14.21

6.4

3.9

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

656

3300

1.40

14.19

3.6

—

Giant cell arteritis

159

3.36

14.18

3.0

4.3

—

Injury, poisoning and certain other consequences of external causes

387

1236

1.57

14.18

3.9

3.4

—

Spontaneous rupture of synovium and tendon

259

2.78

14.17

3.8

4.3

—

Visual disturbances and blindness

352

2263

1.56

14.12

3.8

3.6

—

Infection due to other mycobacteria

6.90

14.12

7.5

2.7

—

Gingival hyperplasia

103

3.98

14.04

3.3

3.5

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

289

1198

1.66

14.03

4.6

2.9

—

Other retinal disorders

456

2475

1.49

14.03

3.8

3.7

—

Dental caries 3

599

2145

1.43

14.02

3.7

3.8

—

Other disorders of patella

114

520

2.21

14.01

3.7

3.8

—

Other anxiety disorders

264

1401

1.68

13.93

2.7

3.5

—

Ankylosing spondylitis

284

2.67

13.93

2.2

4.1

—

Non-selective monoamine reuptake inhibitors

274

1614

1.66

13.89

3.3

3.9

—

Asthma (diagnoses ohter than nonallergic)

587

3568

1.41

13.88

3.3

3.6

—

Other diseases of upper respiratory tract

796

3061

1.36

13.83

3.8

3.6

—

Dental operations, only avohilmo

520

1822

1.47

13.82

3.6

3.7

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

201

654

1.85

13.81

3.8

3.1

—

Demyelinating diseases of the central nervous system

246

2.80

13.79

3.2

3.4

—

Intracranial trauma

370

1789

1.55

13.77

3.8

3.6

—

Sequelae of external causes of morbidity and mortality

184

1003

1.85

13.76

3.9

4.0

—

Decubitus ulcer and pressure area

204

3.00

13.67

3.8

3.7

—

Other CVD (FINNGEN)

284

2.49

13.64

4.0

3.2

—

Benign neoplasm: Caecum

270

2.70

13.64

4.2

3.2

—

Total colectomy

138

3.48

13.64

2.5

4.3

—

Total colectomy operation

138

3.48

13.64

2.5

4.3

—

Personal history of malignant neoplasm

101

3.94

13.57

5.4

3.3

—

Aspergillosis

6.75

13.50

12.2

3.7

—

Charcot foot

5.02

13.45

2.8

4.8

—

Benign neoplasm: Adrenal gland

159

3.25

13.42

3.4

3.7

—

Other ulcerative colitis

165

3.20

13.31

3.9

4.0

—

Mood disorders

681

3261

1.38

13.31

3.3

3.6

—

Acute pancreatitis

148

760

1.96

13.31

4.1

—

Type 2 diabetes, definitions combined, including avohilmo

644

2746

1.39

13.29

3.2

3.8

—

Cerebrovascular diseases

531

2666

1.43

13.29

3.8

—

Peripheral artery disease

336

1734

1.57

13.26

3.7

3.9

—

Other otitis externa (chronic)

213

2.91

13.25

3.5

4.3

—

Mood [affective] disorders

679

3257

1.37

13.25

3.3

3.6

—

Irritable bowel syndrome

179

979

1.84

13.24

3.5

3.6

—

Disorders of synovium and tendon

340

1977

1.55

13.21

3.7

—

Poisoning by medicine

136

681

2.01

13.12

3.0

3.8

—

Atrial fibrillation and flutter with reimbursement

181

623

1.87

13.06

3.8

3.7

—

Temporal arteritis

138

3.42

12.96

2.9

4.2

—

Bipolar affective disorders

119

570

2.10

12.96

2.8

3.7

—

Fracture of lumbar spine and pelvis

158

836

1.90

12.95

3.7

4.0

—

Other juvenile arthritis

109

3.73

12.95

2.8

4.7

—

Later onset COPD

224

1024

1.73

12.94

3.2

3.9

—

Hepatomegaly and splenomegaly, not elsewhere classified

7.01

12.88

5.6

4.1

—

Impingement syndrome of shoulder

182

1011

1.81

12.84

3.4

3.9

—

Other and unspecified local infections of skin and subcutaneous tissue

326

2.49

12.83

3.5

4.2

—

Other gastritis (incl. Duodenitis)

165

891

1.87

12.76

3.1

3.7

—

Pneumococcal septicemia

120

3.59

12.74

3.5

3.9

—

Artificial joint operation, meniscal resection

629

3037

1.38

12.72

3.3

3.8

—

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

274

2.62

12.72

3.7

3.2

—

Intestinal adhesions without obstruction

275

2.62

12.66

3.3

3.7

—

Drug-induced polyneuropathy

6.01

12.63

7.1

3.5

—

Depression or dysthymia

492

1905

1.45

12.61

3.3

4.0

—

Otitis externa

155

825

1.89

12.54

3.4

3.9

—

Acute posthaemorrhagic anaemia

107

3.72

12.54

7.1

4.1

—

Dental pulpitis 4

762

2946

1.35

12.53

3.5

3.6

—

Etanercept

182

3.01

12.50

3.5

3.7

—

Dental pulpitis 1

762

2948

1.35

12.49

3.5

3.6

—

Benign neoplasm of meninges

231

2.76

12.48

4.5

3.3

—

Insulin, fast-acting

252

1543

1.64

12.45

3.4

3.8

—

Hypersplenism

10.95

12.43

5.9

3.7

—

Endocarditis

122

3.52

12.42

2.7

4.0

—

Abnormal results of function studies

261

2.64

12.35

5.0

3.8

—

Osteomyelitis

239

2.72

12.30

3.6

4.0

—

Hyperlipidaemia, other/unspecified

279

1661

1.60

12.30

3.6

3.8

—

Benign neoplasm: Colon

372

2445

1.50

12.28

3.9

3.8

—

Giant cell arteritis with polymyalgia rheumatica

143

3.30

12.27

2.9

4.2

—

Rheumatism, unspecified

102

471

2.19

12.25

3.1

3.9

—

Other specified/unspecified bacterial intestinal infections

217

2.81

12.25

3.2

3.9

—

Dental pulpitis 2, only avohilmo

526

1891

1.43

12.23

4.1

3.7

—

Hyperkalaemia

190

2.95

12.22

4.8

4.5

—

Hypopituitarism

251

2.67

12.22

4.3

4.9

—

Dorsalgia

665

2642

1.37

12.12

3.4

3.6

—

Other intervertebral disc disorders

558

2444

1.40

12.12

3.3

3.6

—

Ankylosing spondylitis, ICD10

293

2.52

12.11

2.2

4.1

—

Suicide or other Intentional self-harm

154

828

1.87

12.08

2.7

3.8

—

Other diseases of intestine

429

2.24

12.08

3.3

4.3

—

Ascites

230

2.73

12.06

3.6

4.4

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

262

1623

1.61

12.05

4.1

3.7

—

Diseases of pulp and periapical tissues, including avohilmo

757

2943

1.34

12.03

3.6

—

Lack of expected normal physiological development

5.14

11.98

2.1

1.8

—

Oesophageal varices

151

3.18

11.87

6.2

4.4

—

Hodgkin lymphoma, hilmo

102

3.72

11.85

4.7

3.4

—

Cholecystitis

108

518

2.10

11.79

3.6

4.3

—

Acute pancreatitis (for exclusion)

148

793

1.88

11.78

4.1

4.0

—

Hyperplasia of prostate

278

986

1.62

11.77

4.2

4.1

—

Cystic kidney disease

112

3.57

11.76

3.7

3.8

—

Haemorrhoids and perianal venous thrombosis

203

1194

1.71

11.74

3.6

—

Diabetes medication

686

3101

1.35

11.73

3.2

3.7

—

Infectious mononucleosis

211

2.77

11.69

5.3

3.6

—

Other (not insulin) diabetes medications

646

2871

1.36

11.68

3.0

3.8

—

Dizziness and giddiness

501

2900

1.41

11.65

3.5

3.6

—

Cirrhosis of liver, NAS

190

2.90

11.65

4.0

4.2

—

Special screening examination for neoplasms

103

3.65

11.63

2.2

3.9

—

Non-small cell lung cancer, adenocarcinoma

247

2.64

11.57

2.2

4.4

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

247

2.64

11.57

2.2

4.4

—

Spinal stenosis

366

1931

1.49

11.54

3.8

—

Eosinophilia

4.82

11.52

5.3

3.6

—

Juvenile rheumatoid arthirtis

5.11

11.51

3.0

5.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

102

483

2.13

11.50

3.1

3.4

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

4.79

11.50

3.1

3.7

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

103

490

2.12

11.49

4.2

3.0

—

Colectomy operation

130

674

1.95

11.46

2.8

4.4

—

Peripheral artery operations in Hilmo

108

524

2.08

11.45

2.9

4.1

—

Haemorrhage, not elsewhere classified

114

3.49

11.44

4.5

3.4

—

Other disorders of bone

133

696

1.92

11.38

3.6

4.0

—

Atherosclerosis, excluding cerebral and coronary sclerosis

311

1624

1.54

11.36

3.6

3.9

—

Injuries to the thorax

301

1966

1.54

11.36

3.6

3.8

—

Fracture of rib(s), sternum and thoracic spine

205

1222

1.69

11.34

3.6

3.9

—

Amputation of toe

273

2.53

11.34

3.1

4.0

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

333

2.36

11.33

3.9

3.1

—

Sequelae of cerebrovascular disease

258

1424

1.60

11.32

3.9

—

Molar incisor enamel hypoplasia

132

3.28

11.30

6.0

3.4

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

169

955

1.78

11.30

2.7

3.6

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

12.03

11.24

8.6

6.4

—

Other diseases of pericardium

156

3.07

11.24

6.5

3.5

—

Listeriosis

11.74

11.20

18.1

3.2

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

112

556

2.03

11.15

2.5

2.9

—

Benign neoplasm of colon, rectum, anus and anal canal

429

2720

1.43

11.08

3.8

—

Abscess of lung

4.81

11.05

3.7

4.0

—

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

282

2.47

11.04

3.7

3.3

—

Spirochaetal infections, other/unspecified

289

2.45

10.99

4.5

4.1

—

Fracture of lower leg, including ankle

354

2400

1.47

10.95

3.2

3.6

—

Bacterial pneumonia, not elsewhere classified

224

1214

1.64

10.95

3.6

3.3

—

Selective serotonin reuptake inhibitors

685

2700

1.34

10.94

3.1

3.8

—

Conduction disorders

211

1056

1.67

10.93

3.9

3.7

—

Abnormal findings on diagnostic imaging of other body structures

409

2.20

10.88

4.4

3.7

—

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

118

3.35

10.83

2.6

3.2

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

6.44

10.82

4.6

5.2

—

Vertigo of central origin

4.72

10.82

7.5

3.8

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

154

829

1.81

10.80

2.8

3.0

—

Disorders of sclera, cornea, iris and ciliary body

343

2328

1.48

10.79

3.4

3.6

—

Weight loss

366

2.27

10.79

3.4

4.2

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

165

2.95

10.78

2.5

3.1

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

398

2.20

10.75

4.3

3.0

—

Psoriatic arthropathies

311

2.37

10.68

2.2

4.3

—

Other arthrosis

329

1574

1.50

10.59

3.0

3.9

—

Viral hepatitis, IBD co-morbidity

100

3.53

10.59

2.9

3.8

—

Thyroiditis, ILD-related definition

331

2.32

10.57

3.0

3.9

—

Benign neoplasm of mouth and pharynx

270

2.47

10.55

4.0

3.1

—

Use of interferon beta-1a

4.89

10.53

3.3

3.6

—

Seborrhoeic dermatitis

332

2.31

10.52

4.5

3.9

—

Hypoplasia of dental enamel , including avohilmo

119

3.32

10.52

6.4

3.6

—

Insulin, fast-acting or short human

254

1626

1.57

10.52

3.4

3.9

—

Diseases of salivary glands

123

645

1.92

10.50

3.5

3.7

—

Use of pramipexole

156

882

1.78

10.49

3.2

4.1

—

Allergic urticaria

265

2.48

10.49

5.7

3.8

—

Leiomyoma of uterus

218

740

1.67

10.44

3.8

2.7

—

Other dorsopathies, not elsewhere classified

669

2656

1.33

10.36

3.4

3.6

—

Recurrent or chronic depression

237

1071

1.60

10.30

2.6

3.8

—

Other condition

458

2.09

10.30

4.4

3.9

—

Soft tissue disorders related to use, overuse and pressure

176

1035

1.71

10.29

3.7

3.9

—

Hyperparathyroidism

130

691

1.87

10.27

3.7

3.8

—

Acetic acid derivatives and related substances

199

610

1.71

10.23

3.8

4.7

—

Other infectious diseases

293

2.39

10.21

7.6

3.8

—

Alcohol use disorder, Swedish definition

368

2372

1.45

10.21

2.6

3.9

—

Other disorders involving the immune mechanism, not elsewhere classified

113

3.35

10.19

8.8

3.7

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

329

2195

1.47

10.15

3.7

3.6

—

Open wound of head

351

2387

1.45

10.12

3.6

3.8

—

Malignant neoplasm of eye, brain and central nervous system

139

3.08

10.12

4.3

4.4

—

Bacterial pneumonia (organism specified)

304

1855

1.50

10.11

5.0

3.7

—

Diaphragmatic hernia

252

1628

1.56

10.09

4.4

3.7

—

Chronic pancreatitis

442

2.10

10.09

2.1

4.2

—

211

1154

1.63

10.07

3.8

4.0

—

Malignant neoplasm of mesothelium and soft tissue

161

2.91

10.07

2.8

4.5

—

Other CVD

139

770

1.82

10.02

3.9

4.3

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

265

2.45

10.02

3.8

3.9

—

Deforming dorsopathies

191

1158

1.66

9.97

3.2

3.7

—

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

9.64

9.95

4.0

—

Arthropathic psoriasis

379

2.18

9.93

2.1

4.2

—

Abnormal findings on examination of blood, without diagnosis

331

2122

1.47

9.90

4.5

3.9

—

Concussion

300

1740

1.50

9.89

3.5

3.6

—

Spondylopathies in diseases classified elsewhere

4.89

9.88

4.5

2.9

—

Other symptoms and signs involving the circulatory and respiratory systems

214

2.60

9.81

4.5

3.6

—

Marginal zone B-cell lymphoma

5.58

9.77

6.4

3.0

—

Primary gonarthrosis, bilateral

350

2123

1.45

9.76

3.3

3.9

—

Focal epilepsy, strict definition

137

762

1.81

9.75

3.4

4.2

—

Mental and behavioural disorders due to opioids

3.71

9.73

2.5

3.0

—

Pain associated with micturition

402

2.13

9.72

3.2

3.9

—

Monocytic leukaemia

19.76

9.68

18.0

4.5

—

Injuries to the hip and thigh

308

1912

1.48

9.67

3.8

—

Other specified/unspecified necrotizing vasculopathies

4.94

9.62

3.2

3.6

—

Opening and dilatation of root channel of tooth

193

2.68

9.62

4.5

4.0

—

Other abnormalities of plasma proteins

4.75

9.62

4.0

3.7

—

Acute and subacute iridocyclitis

127

694

1.84

9.59

3.6

3.9

—

ILD-related respiratory insufficiency

128

3.12

9.59

7.1

4.8

—

Abnormality of white blood cells, not elsewhere classified

5.76

9.58

10.1

3.1

—

Benign neoplasm: Cerebral meninges

205

2.61

9.56

4.1

3.3

—

Palindromic rheumatism

5.67

9.54

2.3

5.5

—

Benign neoplasm: Transverse colon

253

2.43

9.52

3.0

3.3

—

Familial hypercholesterolemia, with ischemic heart disease

426

2.09

9.51

2.9

4.0

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

212

1333

1.59

9.49

3.1

3.6

—

Obsessive-compulsive disorder

155

2.87

9.48

3.5

3.3

—

Disorders of skin appendages

288

1939

1.49

9.48

4.2

3.5

—

Pain and other conditions associated with female genital organs and menstrual cycle

114

578

1.90

9.47

3.3

2.9

—

Other disorders of veins

242

1572

1.55

9.45

3.5

—

Iridocyclitis

149

859

1.75

9.41

3.4

4.0

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

455

2.03

9.34

2.5

3.3

—

Hypotension

119

644

1.86

9.30

4.1

4.2

—

Other overlap syndromes

4.26

9.24

2.4

4.4

—

Other inflammatory liver diseases

215

2.54

9.22

2.8

3.9

—

Recurring oral aphthae

158

2.83

9.21

8.3

3.8

—

Dermatophytosis

479

2.00

9.18

4.8

4.0

—

Malignant neoplasm of breast

294

1431

1.49

9.18

2.5

3.6

—

Anomalies of dental arch relationship, including avohilmo

123

603

1.84

9.18

4.2

3.4

—

Asthma/COPD (KELA code 203)

618

3326

1.31

9.17

3.2

3.7

—

Disorders of vestibular function (Vertigo)

305

2080

1.46

9.14

3.8

3.7

—

Primary biliary cholangitis (PBC)

4.50

9.13

3.0

—

Monocytic leukaemia

7.48

9.13

18.0

5.0

—

395

2541

1.40

9.08

2.6

3.9

—

Pruritus

361

2.15

9.04

3.5

3.8

—

Glomerulonephritis

368

2.14

9.02

4.3

4.2

—

Explicit fungal Sepsis

7.05

9.00

2.6

4.8

—

Lower back pain or/and sciatica

654

3499

1.30

9.00

3.4

3.6

—

Anterior Iridocyclitis

132

745

1.78

9.00

3.6

4.0

—

Diseases of inner ear

351

2428

1.42

8.99

3.8

3.7

—

Ankylosing spondylitis, strict definition

122

3.08

8.99

2.6

3.5

—

Serous carcinoma of ovary

107

3.24

8.95

2.3

3.3

—

Hypertensive heart and/or renal disease

186

885

1.64

8.95

3.4

4.0

—

Chronic tubulo-interstitial nephritis

112

3.17

8.94

4.6

4.0

—

Erosion of teeth

4.44

8.93

3.3

3.4

—

Focal epilepsy

144

835

1.73

8.92

3.5

4.3

—

Dental caries 3, only avohilmo

587

2267

1.33

8.92

3.6

3.8

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

128

718

1.79

8.91

3.5

4.3

—

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

7.46

8.90

2.1

3.6

—

Sequelae with surgical and medical care as external cause

139

801

1.75

8.84

3.8

4.3

—

Other mycoses, not elsewhere classified/unspecified

10.96

8.78

6.8

3.4

—

Optic neuritis

124

3.03

8.76

3.9

3.5

—

Adrenocortical insufficiency

119

3.08

8.74

3.7

4.3

—

Systemic disorders of connective tissue in diseases classified elsewhere

10.68

8.74

5.5

3.7

—

Benign neoplasm: Ascending colon

340

2.16

8.72

3.5

3.0

—

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

5.11

8.66

2.3

3.6

—

Benign neoplasm: Skin of other and unspecified parts of face

277

2.29

8.65

4.5

3.2

—

Ulcerative proctitis

169

2.69

8.65

4.8

3.7

—

Assault by bodily force

198

2.55

8.64

2.6

3.8

—

Hypoparathyroidism

120

3.06

8.63

3.4

3.8

—

Abnormalities of heart beat

216

1386

1.55

8.62

3.3

—

Hernia

608

3169

1.30

8.61

3.9

3.6

—

Fissure and fistula of anal and rectal regions

153

913

1.68

8.56

4.5

3.8

—

Sacroiliitis, not elsewhere classified

115

3.08

8.56

2.1

3.4

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

158

952

1.67

8.54

2.2

4.2

—

Carpal tunnel syndrome

374

2431

1.39

8.52

3.4

3.6

—

Hidradenitis suppurativa

100

3.25

8.52

2.1

3.3

—

Amyloidosis

3.76

8.51

3.2

4.6

—

151

850

1.69

8.51

3.7

4.1

—

Amyloidosis, other/unspecified

3.99

8.50

2.6

4.4

—

Diabetic nephropathy, excluding more controls

105

466

1.90

8.45

3.0

3.3

—

Herpesviral [herpes simplex] infections

385

2.07

8.41

4.3

4.0

—

Other disorders of optic [2nd] nerve and visual pathways

219

2.45

8.41

4.8

4.5

—

Alcoholic liver disease

359

2.11

8.39

2.7

4.2

—

Other disorders of adrenal gland

155

2.75

8.38

3.5

4.2

—

Other and unspecified tonsillitis

172

897

1.63

8.35

2.7

3.2

—

Tobacco use

161

2.71

8.34

3.5

3.9

—

Folate deficiency anaemia

5.59

8.30

5.9

4.6

—

Hallux valgus (acquired)

201

925

1.58

8.29

3.9

3.8

—

Open wound of lower leg

511

1.91

8.29

3.4

4.1

—

Car occupant injured in other and unspecified transport accidents

114

632

1.81

8.28

3.8

3.7

—

Malignant neoplasm of other connective and soft tissue

3.50

8.28

2.7

4.5

—

Peripheral arterial reconstruction

125

713

1.77

8.27

3.2

4.1

—

Diseases of male genital organs

360

1287

1.42

8.27

4.2

4.1

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

6.37

8.26

3.3

—

Other disorders of nervous system

227

2.41

8.26

5.4

4.3

—

Dental caries 2 and operation codes

447

2638

1.35

8.24

3.7

3.5

—

Abscess of anal and rectal regions

246

2.34

8.20

2.6

4.1

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

108

3.12

8.18

9.6

3.8

—

Other diseases of stomach and duodenum

198

2.50

8.15

3.6

3.8

—

Otitis media, unspecified

363

2.04

8.15

3.9

3.3

—

Assault

363

2.08

8.14

2.8

3.9

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

207

1347

1.54

8.13

4.5

3.6

—

Hard cardiovascular diseases

528

2573

1.32

8.12

3.8

—

Dental caries 2

455

2670

1.34

8.09

3.7

3.5

—

Hernia of abdominal wall

292

2039

1.44

8.08

3.5

3.9

—

Open wound of forearm

312

2.17

8.05

4.8

4.3

—

Crystal arthropathies, rheuma endpoint

3.94

8.03

5.0

4.3

—

Other noninflammatory disorders of vagina

236

2.35

8.03

2.4

3.5

—

Unspecified acute lower respiratory infection

517

1.89

8.01

5.5

4.0

—

Melanocytic naevi

134

787

1.71

7.98

4.4

2.9

—

Other and unspecified acquired haemolytic anaemias

5.07

7.98

8.7

4.0

—

Malignant neoplasm of breast, HER2-negative

281

1423

1.46

7.98

2.5

3.6

—

371

2482

1.38

7.93

2.6

3.9

—

Chondropathies

526

1.88

7.92

2.9

4.0

—

Dental caries 1, only avohilmo

556

2170

1.31

7.92

3.7

3.8

—

Transport accidents

261

1583

1.47

7.91

3.3

3.6

—

Other specific arthropathies, wide

3.85

7.84

2.7

4.2

—

Care involving use of rehabilitation procedures

175

2579

0.64

7.83

3.9

3.7

—

Other diseases of pancreas

239

2.33

7.82

3.4

3.8

—

Other and unspecified immunodeficiencies with predominantly antibody defects

4.32

7.81

7.1

3.4

—

Abnormal weight loss

336

2.11

7.81

3.1

4.1

—

Sequelae of injuries, of poisoning and of other consequences of external causes

145

876

1.66

7.80

3.9

4.0

—

Fracture of foot, except ankle

143

861

1.67

7.79

3.3

3.8

—

Osteonecrosis

197

2.47

7.76

5.5

4.1

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

157

523

1.67

7.75

3.4

5.0

—

Malignant neoplasm of brain

101

3.12

7.74

5.1

4.5

—

Rotator cuff syndrome

383

2082

1.37

7.73

3.2

3.8

—

Faecal incontinence

285

2.20

7.71

4.2

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

282

1974

1.43

7.68

2.5

4.0

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

8.90

7.67

3.5

3.0

—

Congenital malformations, deformations and chromosomal abnormalities

341

2363

1.39

7.67

3.5

—

Congenital malformations of the urinary system

223

2.36

7.64

4.5

4.8

—

Schizophrenia or delusion, excluding more controls

169

1057

1.59

7.64

3.1

3.9

—

Allergic asthma (mode), excluding more controls

103

557

1.82

7.63

2.5

2.9

—

Artrosis, including avohilmo

543

2285

1.31

7.59

3.5

3.8

—

Reactive arthropathies

268

2.22

7.56

4.0

4.5

—

Cervical disc disorders

233

1581

1.48

7.53

4.7

3.6

—

Atopic dermatitis

303

1834

1.41

7.53

3.5

3.4

—

TMD related operations

514

1.86

7.51

4.0

3.8

—

Myocarditis

108

2.99

7.50

4.0

4.1

—

Ventral hernia

158

986

1.61

7.49

3.5

3.9

—

Infarction of spleen

6.27

7.48

8.9

3.8

—

UC patients in KELA-register (code 208), prior to 1994

159

2.62

7.47

3.9

4.1

—

Degeneration of macula and posterior pole

318

1879

1.40

7.46

3.6

3.8

—

Other/unspecified dorsalgia

230

1552

1.48

7.45

3.1

3.6

—

Benign neoplasm: Colon, unspecified

168

1066

1.59

7.44

3.9

4.0

—

Correction of physiology of bite - demanding therapy visit

207

2.39

7.44

4.4

3.6

—

Small cell lung cancer, helper endpoint

3.25

7.44

1.9

3.8

—

Small cell lung cancer

3.25

7.44

1.9

3.8

—

Pneumothorax

251

2.26

7.43

3.8

3.5

—

Other shoulder lesions

270

2.20

7.43

3.2

4.3

—

Biguanides

604

2912

1.28

7.42

2.8

3.8

—

Pyothorax

154

2.64

7.40

3.9

4.7

—

Brain meningioma, excluding all cancers (controls excluding all cancers)

120

2.87

7.39

3.3

3.6

—

Dorsopathies

667

2686

1.27

7.38

3.7

3.6

—

Bronchitis, not specified as acute or chronic

284

2.17

7.37

4.7

4.5

—

Postmenopausal osteoporosis with pathological fracture

190

2.45

7.35

3.0

3.8

—

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

115

2.90

7.32

4.8

3.5

—

Allergic asthma (mode)

103

566

1.79

7.27

2.5

2.9

—

Chronic sinusitis

249

1724

1.45

7.24

3.5

3.6

—

Atypical mycobacterium lung infection

4.86

7.22

8.5

4.1

—

Thrombotic microangiopathy

7.19

7.22

6.8

3.8

—

Phobic anxiety disorders

346

2.03

7.21

2.8

3.7

—

Myocardial infarction, without ST-elevation

273

1774

1.43

7.20

3.4

4.0

—

Acidosis

3.52

7.17

1.7

5.3

—

Elevated blood glucose level

294

2.13

7.17

4.7

4.0

—

Other neurological diseases

468

2877

1.31

7.17

3.7

—

Alcohol use disorder, ICD-based

257

1795

1.44

7.17

2.5

4.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

110

611

1.75

7.15

3.9

4.1

—

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

101

3.01

7.09

4.3

2.8

—

Panic disorder

397

1.95

7.06

2.5

3.7

—

Generalized anxiety disorder

425

1.92

7.06

2.8

3.4

—

Selective deficiency of immunoglobulin G [IgG] subclasses

5.43

7.05

4.1

2.7

—

Amputation of thigh

107

2.95

7.05

3.8

5.0

—

Personality disorders, excluding more controls

126

755

1.68

7.03

2.7

3.8

—

Carrier of infectious disease

3.45

7.01

4.5

3.7

—

Lung diseases due to external agents

100

563

1.79

7.00

4.3

4.0

—

Colonic or urogenital fistula

169

1090

1.56

6.99

4.4

4.0

—

Viral warts

324

2.05

6.97

3.7

4.2

—

Osteonecrosis due to drugs

4.10

6.97

5.1

4.1

—

Ulcerative ileocolitis

113

2.87

6.97

3.4

3.8

—

Disorders of muscles

304

2.09

6.96

4.4

4.1

—

Conjunctivitis

434

2878

1.32

6.96

3.8

3.5

—

Postzoster neuralgia

4.07

6.95

4.4

4.3

—

Abnormal findings on diagnostic imaging of central nervous system

130

2.73

6.95

3.7

3.9

—

Cerebral palsy and other paralytic syndromes

407

1.93

6.94

3.5

4.0

—

Benign neoplasm: Skin of eyelid, including canthus

421

1.91

6.93

3.8

3.0

—

TMD related pain

3.09

6.91

2.3

3.3

—

Erosion of teeth, including avohilmo

122

703

1.68

6.90

2.8

3.4

—

Perforation of tympanic membrane

347

2.01

6.83

3.9

3.8

—

Other forms of systemic lupus erythematosus

5.61

6.83

2.8

4.3

—

In situ neoplasms

221

1516

1.46

6.82

4.7

3.5

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

2.99

6.82

7.6

3.4

—

Disorders of conjunctiva

485

3144

1.29

6.81

3.9

3.4

—

Idiopathic gout

341

2.01

6.80

4.3

4.2

—

Benign neoplasm: Tongue

3.68

6.77

6.2

4.0

—

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

4.53

6.74

6.1

3.0

—

Emotionally unstable personality disorder

335

2.01

6.73

2.5

3.4

—

Neuralgia and neuritis, unspecified

138

2.64

6.73

4.0

4.3

—

Primary ovarian failure

4.77

6.71

2.2

3.9

—

Amputation of foot

3.05

6.70

3.8

4.5

—

Gonarthrosis, primary, with knee surgery

369

2253

1.34

6.68

3.4

3.9

—

Other viral hepatitis

162

2.49

6.68

2.8

4.0

—

Mental and behavioural disorders due to alcohol

314

2236

1.37

6.68

2.6

3.9

—

Meniscus derangement

332

1664

1.37

6.67

3.6

3.9

—

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

105

2.89

6.65

4.1

3.1

—

Calcific aortic valvular stenosis, diagnosis (helper)

198

1308

1.49

6.63

4.5

3.8

—

Operations 2 for CAVS

198

1308

1.49

6.63

4.5

3.8

—

Other disorders of bladder

435

1.88

6.63

4.2

4.3

—

Ulcerative rectosigmoiditis

244

2.19

6.62

4.4

—

Extreme obesity with alveolar hypoventilation

128

2.70

6.60

2.2

4.6

—

Other embolism and thrombosis

457

1.85

6.60

4.6

3.9

—

Hypertensive Heart Disease

158

827

1.57

6.60

3.1

4.0

—

Psoriatic arthropathies, ICD10

366

1.96

6.57

2.2

4.1

—

Calcific aortic valvular stenosis, including rheumatic fever

198

1310

1.49

6.56

4.5

3.8

—

Inflammatory disease of cervix uteri

176

2.41

6.53

2.9

3.7

—

Other diseases of oesophagus

346

1.98

6.53

3.3

3.7

—

Diabetic neuropathy

442

1.86

6.53

3.9

3.8

—

Benign neoplasm of other and unspecified endocrine glands

459

1.84

6.52

4.7

4.0

—

Calcific aortic valvular stenosis, operated

198

1313

1.48

6.51

4.5

3.8

—

Calcific aortic valvular stenosis

198

1313

1.48

6.51

4.5

3.8

—

Carcinoma in situ of skin of other and unspecified parts of face

214

2.26

6.49

7.8

3.2

—

Endometriosis

186

728

1.52

6.48

3.0

3.1

—

Speech disturbances, not elsewhere classified

320

2.02

6.47

2.7

3.9

—

Acute lymphadenitis

177

2.40

6.46

7.4

4.1

—

Chronic diseases of tonsils and adenoids

474

2321

1.30

6.46

3.4

3.6

—

Other renal tubulo-interstitial diseases

3.44

6.45

3.5

4.4

—

Other sleep disorders

356

1.95

6.38

3.4

4.5

—

Atopic dermatitis, strict definition with reimbursement

160

1009

1.54

6.38

3.1

3.3

—

Oxicams

154

553

1.59

6.37

3.8

4.8

—

Hypertensive Renal Disease

119

2.73

6.37

4.3

3.7

—

Parodontitis or/and operation codes

420

1902

1.32

6.37

3.8

3.7

—

Viral and other specified intestinal infections

119

705

1.66

6.36

3.7

3.5

—

Polyarteritis nodosa

5.68

6.35

5.8

3.1

—

Olecranon bursitis

210

2.26

6.34

3.5

4.3

—

Spinal instabilities

3.13

6.34

3.1

3.9

—

Other psoriatic arthropathies

350

1.96

6.34

2.3

4.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

171

1131

1.52

6.32

3.4

3.6

—

Benign neoplasm of eye and adnexa

249

2.14

6.31

3.1

—

Complications following infusion, transfusion and therapeutic injection

3.93

6.31

2.4

4.1

—

Examination and encounter for administrative purposes

2.97

6.28

5.7

3.3

—

Duodenal ulcer

436

1.85

6.28

2.9

4.1

—

Personal history of medical treatment

4.83

6.27

12.4

3.5

—

Injuries to the elbow and forearm

415

2883

1.30

6.27

3.4

3.6

—

Portal vein thrombosis

3.75

6.25

5.5

4.7

—

Encephalitis

2.91

6.24

3.3

3.9

—

Dermatopolymyositis (FG)

4.05

6.21

4.9

4.1

—

Other crystal arthropathies

3.28

6.20

5.0

3.9

—

Other encephalitis

2.96

6.19

3.3

4.0

—

Haemophagocytic lymphohistiocytosis

18.15

6.19

8.0

4.3

—

malignant neoplasm of female genital organs

533

1.76

6.18

2.4

3.7

—

Inflammatory diseases of prostate (prostatitis)

482

1.80

6.17

2.9

3.8

—

Syphilis

3.01

6.15

2.0

3.7

—

Postprocedural disorders of digestive system, not elsewhere classified

110

2.77

6.14

3.3

4.2

—

Stroke, excluding SAH

399

2266

1.31

6.14

3.8

3.7

—

Visual disturbances

286

2094

1.37

6.14

3.9

3.6

—

Crowding of teeth, including avohilmo

261

2.01

6.10

4.1

3.1

—

Injuries to the shoulder and upper arm

518

3443

1.26

6.08

3.4

3.7

—

Benign neoplasm: Rectum, anus and anal canal

573

1.72

6.06

3.8

3.0

—

Golimumab

3.12

6.06

2.5

3.4

—

Temporomandibular joint disorders, including avohilmo

214

1492

1.44

6.05

3.0

3.4

—

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

5.36

6.05

7.2

3.7

—

2.98

6.04

3.7

5.1

—

Kela reimbursement Agammaglobulinemia (D80-84)

4.99

6.03

3.5

3.6

—

ILD and respiratory illness in diseases classified elsewhere

6.58

6.02

4.3

3.6

—

Severe visual impairment, binocular

6.57

6.02

4.0

5.8

—

Disorder of lipoprotein metabolism, unspecified

530

1.75

6.02

3.2

4.3

—

Use of disulfiram, acamprosate or naltrexone

261

2.09

6.00

2.7

4.3

—

Diseases of tongue

196

2.27

6.00

4.5

3.5

—

Adverse effects, not elsewhere classified

115

704

1.64

5.99

3.7

3.8

—

Diabetic nephropathy

106

628

1.68

5.97

3.2

3.6

—

Other benign neoplasms of uterus

129

2.59

5.97

2.5

3.2

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

109

632

1.66

5.96

3.2

2.9

—

Other/unspecified synovitis and tenosynovitis

379

1.89

5.96

4.8

4.0

—

Reactive arthropathies, FINNGEN

203

2.24

5.95

3.2

4.6

—

Superficial injury of hip and thigh

517

1.75

5.93

4.5

4.1

—

Benign neoplasm: Skin, unspecified

3.07

5.93

3.3

3.6

—

Occupational exposure to risk-factors

118

2.67

5.93

7.3

5.1

—

Chronic iridocyclitis

166

2.38

5.91

3.3

3.9

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

172

2.34

5.90

2.2

3.1

—

Benign neoplasm of brain and other parts of central nervous system

142

2.49

5.86

3.2

—

Thyroiditis, unspecified

4.25

5.85

2.3

3.7

—

Bronchiectasis

298

2.00

5.85

3.2

4.5

—

Carcinoma in situ of skin

205

2.21

5.82

7.5

3.3

—

Secondary malignant neoplasm of respiratory and digestive organs

3.71

5.82

1.4

4.5

—

Other and unspecified follicular disorders

125

2.59

5.81

7.5

3.8

—

Other noninfective disorders of lymphatic vessels and lymph nodes

108

2.72

5.78

1.9

3.3

—

Corns and callosities

232

2.13

5.77

3.4

4.1

—

Dyshidrosis [pompholyx]

3.98

5.75

1.6

4.9

—

Enteropathic arthropathies

3.39

5.74

2.5

4.6

—

Fracture of femur

166

1017

1.50

5.73

3.8

3.9

—

Other and unspecified injuries of ankle and foot

120

2.61

5.73

3.6

4.1

—

KRA_PSY_EATING, excluding more controls

180

2.28

5.73

3.3

3.1

—

Orchitis and epididymitis

314

1.96

5.72

4.0

—

Somatoform disorder

531

1.72

5.70

3.5

4.1

—

Malignant neoplasm of bone and articular cartilage

4.21

5.69

2.7

4.4

—

Asthma, hospital admissions , main diagnosis only

500

3569

1.26

5.68

3.3

3.6

—

Dermatopolymyositis

3.78

5.68

4.9

—

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

6.04

5.66

1.9

4.2

—

Pneumonitis due to solids and liquids

288

2.00

5.65

2.3

4.4

—

Allergic purpura

2.91

5.64

4.0

3.5

—

Embedded and impacted teeth

123

657

1.60

5.64

3.5

3.2

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

570

1.69

5.64

3.0

—

Carcinoma in situ of breast, intraductal

195

2.22

5.63

3.1

3.4

—

Disorders of continuity of bone

316

1.95

5.63

4.5

3.9

—

Systemic sclerosis (FG)

3.24

5.62

3.3

4.3

—

Benign neoplasm: Parotid gland

176

2.29

5.62

2.1

3.1

—

Left bundle-branch block

255

2.06

5.60

4.7

4.0

—

Spondylolisthesis/Spondylolysis

116

725

1.61

5.60

3.2

4.0

—

Erythema nodosum

2.97

5.59

2.3

3.3

—

Emotional disorders starting during childhood or adolecense, excluding more controls

113

2.62

5.58

4.4

3.2

—

Open wound of wrist and hand

251

1811

1.38

5.58

3.6

3.8

—

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

158

2.36

5.57

2.5

3.1

—

Pustular psoriasis

146

2.43

5.56

2.6

3.7

—

Lyme disease

152

1012

1.51

5.54

3.6

4.0

—

Benign neoplasm of other and unspecified female genital organs

2.87

5.52

2.5

3.2

—

Secondary malignant neoplasm of other and unspecified sites

3.57

5.51

1.8

3.8

—

Parodontitis, under 40 years and operation codes

184

2.24

5.50

4.0

2.5

—

Scoliosis

284

1.99

5.50

2.6

3.8

—

Medicines for HER+ breast cancer

199

1362

1.43

5.48

2.2

3.7

—

Benign lipomatous neoplasm

134

870

1.55

5.48

3.1

3.0

—

L02BG Aromatase inhibitors

167

1138

1.47

5.44

2.2

3.7

—

Parodontitis, operation under 40 years and operation codes

185

2.23

5.43

4.0

2.5

—

Other specified disorders of kidney and ureter

106

2.68

5.43

5.5

4.5

—

Benign neoplasm: Caecum

399

1.82

5.42

4.2

4.1

—

Benign leiomyoma with endometriosis

413

1.80

5.42

3.6

3.2

—

Diabetic retinopathy, excluding more controls

162

607

1.51

5.41

3.7

3.2

—

Sequelae of other external causes

173

2.28

5.41

4.2

4.3

—

Allergic bronchopulmonary aspergillosis (ABPA)

11.97

5.38

11.1

2.9

—

Other arrhythmias

356

2094

1.30

5.36

3.8

3.6

—

Otitis externa, unspecified

350

1.87

5.35

3.4

4.1

—

Visual field defects

301

1.94

5.35

3.9

4.0

—

Paraplegia, diplegia of upper limbs

2.97

5.34

4.6

3.9

—

Pollen allergy

104

634

1.63

5.32

3.1

3.5

—

Other spirochaetal diseases

153

1030

1.49

5.31

3.6

4.0

—

Benign neoplasm: Skin of ear and external auricular canal

2.85

5.26

6.6

3.3

—

Lichen simplex chronicus and prurigo

208

2.14

5.24

3.5

4.1

—

Other and unspecified psoriasis

228

2.08

5.23

3.4

4.3

—

Stroke, including SAH

411

2388

1.28

5.23

3.8

—

Benign neoplasm: Sigmoid colon

118

754

1.57

5.22

3.7

4.2

—

Late syphilis

3.56

5.22

2.2

3.3

—

Pediculosis, acariasis and other infestations

189

2.19

5.20

4.2

4.5

—

Follow-up examination after treatment for malignant neoplasms

283

1.96

5.19

3.1

—

Leiomyoma of uterus

324

1395

1.32

5.19

3.6

3.1

—

Erythema multiforme

2.98

5.17

3.5

3.7

—

Non-small cell lung cancer, squamous

177

2.23

5.14

2.6

4.0

—

Non-small cell lung cancer, squamous, helper endpoint

177

2.23

5.14

2.6

4.0

—

Other or unspecified common variable immunodeficiency

10.69

5.12

3.7

4.7

—

Ménière disease

363

1.83

5.11

4.0

4.1

—

Disorders of magnesium metabolism

4.63

5.10

3.6

2.9

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

356

1.84

5.08

7.3

3.0

—

Injury of cranial nerves

5.46

5.08

7.4

3.8

—

Other noninflammatory disorders of uterus, except cervix

127

559

1.56

5.08

3.8

3.2

—

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

4.54

5.06

4.0

3.9

—

Carcinoma in situ of other and unspecified sites

2.80

5.06

5.2

3.1

—

Monoarthritis, not elsewhere classified

122

2.48

5.05

4.4

4.0

—

Other bursopathies

475

1.72

5.04

2.8

4.0

—

Malignant neoplasm of breast, HER-positive

187

1303

1.42

5.04

2.2

3.7

—

Mental and behavioural disorders due to sedatives or hypnotics

198

2.14

5.04

1.8

3.9

—

Other infective otitis externa

185

2.18

5.04

3.2

3.7

—

Parodontitis, under 40 years

198

2.13

5.03

4.0

2.5

—

Parodontitis, under 40 years, or operation codes

198

2.13

5.03

4.0

2.5

—

Other benign neoplasms of skin

223

1626

1.38

5.01

4.0

3.7

—

Other and unspecified diseases of blood and blood-forming organs

2.85

5.01

6.9

3.6

—

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

239

2.02

4.99

2.3

3.1

—

Other benign neoplasm of uterus: Other parts/unspecified

105

2.60

4.98

2.4

3.1

—

Other disorders of penis

359

1.82

4.98

3.5

4.0

—

Intracranial and intraspinal abscess and granuloma

3.77

4.97

6.2

3.2

—

Other and unspecified effects of external causes

149

1012

1.48

4.97

3.7

3.8

—

Excessive attrition of teeth

234

920

1.38

4.96

3.8

3.4

—

Ischaemic Stroke, excluding all haemorrhages

366

2158

1.29

4.96

3.6

3.8

—

Ovarian dysfunction

154

2.29

4.95

2.7

3.2

—

Other chondrocalcinosis

3.58

4.94

4.4

4.3

—

Striking against or struck by other objects

184

1301

1.42

4.94

3.5

3.8

—

Tuberculosis, IBD comorbidity

254

1.98

4.93

4.5

4.1

—

Benign neoplasm of male genital organs

3.53

4.91

7.2

3.7

—

Melanocytic naevi of trunk

275

1.94

4.91

3.4

2.9

—

Alcohol abuse, main dg, excluding more controls

464

1.71

4.90

1.9

4.2

—

Artificial joint re-operation

255

1.98

4.89

2.8

4.1

—

Benign neoplasm of major salivary glands

241

2.00

4.88

2.6

3.2

—

Nail disorders

262

1.96

4.87

4.3

4.4

—

Specific personality disorders

115

743

1.55

4.86

2.7

3.5

—

Hypoplasia of dental enamel, prenatal

4.85

4.86

4.3

3.9

—

Cholecystectomy

418

2944

1.26

4.86

3.9

3.6

—

Any event in hilmo or specialist outpatient

+∞

4.85

5.2

0.0

—

Trochanteric bursitis

443

1.73

4.85

3.7

4.0

—

Small fibre neuropathy

2.68

4.85

7.4

3.9

—

Malignant neoplasm of bladder

277

1.93

4.83

3.0

4.7

—

Other sexually transmitted chlamydial diseases

137

2.35

4.82

3.3

2.9

—

Other superficial injuries of ankle and foot

5.18

4.82

2.3

4.2

—

Gout due to impairment of renal function

3.69

4.82

4.1

3.9

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

5.13

4.81

8.7

4.6

—

Separation of retinal layers (serosa)

138

2.35

4.77

4.2

4.7

—

Viral hepatitis

216

2.05

4.77

2.7

3.9

—

Malignant neoplasm of ovary

138

2.35

4.77

3.0

3.5

—

Viral infections of the central nervous system

223

2.03

4.76

4.9

3.8

—

Amputation of ankle bones

2.84

4.75

2.6

3.7

—

Benign neoplasm: Adrenal gland

265

1.94

4.74

3.4

4.1

—

Schizophrenia, schizotypal and delusional disorders

170

1196

1.43

4.73

3.1

3.7

—

Benign neoplasm: Choroid

126

2.40

4.73

2.8

3.5

—

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

2.82

4.73

1.7

3.3

—

Ovarian cyst

185

753

1.42

4.71

2.8

3.0

—

Vasomotor and allergic rhinitis

200

1427

1.38

4.70

3.3

3.6

—

Anti-inflammatory and antirheumatic products, non-steroids

193

685

1.42

4.69

3.8

4.7

—

Nonalcoholic fatty liver disease

294

1.88

4.69

2.4

4.1

—

Benign neoplasm: Rectum

493

1.67

4.68

3.9

3.0

—

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

3.75

4.67

4.0

4.1

—

Schizophrenia or delusion

169

1191

1.42

4.67

3.1

3.7

—

Use of glatiramer acetate

3.74

4.67

2.3

2.8

—

Disorders of optic nerve, not elsewhere classified

2.95

4.63

4.2

4.5

—

Hypermobility syndrome

115

2.45

4.63

1.4

3.8

—

Other leukaemias of specified cell type

10.83

4.62

19.6

4.9

—

Other headache syndromes

219

1615

1.36

4.61

3.2

3.6

—

Paralytic strabismus

254

1.95

4.59

3.6

4.2

—

Unspecified misadventure during surgical and medical care

186

2.12

4.59

2.6

4.6

—

Cardiomyopathies, Primary/intrinsic

466

1.68

4.58

3.8

3.9

—

L02BX Other hormone antagonists and related agents

227

2.01

4.57

2.2

4.6

—

All dysplastic lesions of the vagina

3.01

4.57

2.4

3.2

—

Drug-induced systemic lupus erythematosus

4.93

4.57

3.7

4.4

—

Fracture of skull and facial bones

120

795

1.52

4.56

3.3

4.2

—

Secondary right heart disease

141

2.30

4.56

6.5

4.2

—

LSIL lesion of the vagina

3.90

4.56

2.5

2.4

—

Varicose veins

379

2269

1.26

4.55

3.9

3.6

—

Use of teriflunomide

4.86

4.55

1.8

4.4

—

Acute laryngitis and tracheitis

342

1.79

4.54

3.9

3.1

—

Preparation and fitting of bite rail to mouth

422

1.71

4.53

3.7

3.8

—

Tonsillectomy and adenotomy

283

1503

1.31

4.52

3.1

3.5

—

Pulmonary eosinophilia, not elsewhere classified

3.68

4.52

6.6

4.0

—

Mixed hyperlipidaemia

148

2.26

4.52

4.7

4.5

—

Anorexia

3.66

4.51

4.6

4.2

—

Mixed conductive and sensorineural hearing loss

453

1.69

4.51

3.7

4.4

—

Wet age-related macular degeneration

112

720

1.54

4.50

4.0

4.2

—

Cardiomyopathy (excluding other)

476

1.67

4.50

3.8

3.9

—

Systemic sclerosis, icd10

2.81

4.47

3.3

3.5

—

Systemic sclerosis

2.81

4.47

3.3

3.4

—

Sudden idiopathic hearing loss

351

1.78

4.42

4.7

4.2

—

Congenital iodine-deficiency syndrome/hypothyroidism

2.65

4.41

4.0

3.7

—

Heartburn

322

1.81

4.41

3.5

4.5

—

Irregular menses

210

1253

1.36

4.39

3.0

—

Right bundle-branch block

125

2.35

4.36

4.5

3.9

—

Other disorders of the genitourinary system

473

1.66

4.35

3.7

3.8

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

170

2.13

4.34

1.9

3.6

—

Malignant neoplasm of skin

392

2364

1.25

4.32

4.7

3.6

—

Benign neoplasm: Anus and anal canal

2.99

4.30

4.9

4.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

173

1245

1.39

4.28

3.3

3.7

—

Oesophageal obstruction

120

2.36

4.27

2.6

4.1

—

Tubulo-interstitial nephritis, not specified as acute or chronic

212

2.00

4.26

2.8

4.0

—

Keratitis

190

1390

1.37

4.25

3.2

3.9

—

Fenamates

341

1.65

4.25

4.1

4.9

—

Pilonidal cyst

233

1.94

4.24

3.7

4.1

—

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

3.67

4.22

2.9

3.4

—

Meningitis

159

2.16

4.22

3.3

4.1

—

Osteopathy in diseases classified elsewhere

4.23

4.21

5.5

3.7

—

Asthma and opportunity respiratory infection

166

2.13

4.21

4.9

4.7

—

Other pulmonary heart/vessel disease

166

2.13

4.20

6.2

4.5

—

Lumbar disc prolapse

361

2286

1.26

4.20

3.3

3.7

—

Arthropathy in Crohn disease

4.17

4.19

2.2

2.4

—

Allergic rhinitis

159

1121

1.41

4.19

2.9

3.5

—

Hypoplasia of dental enamel, prenatal , including avohilmo

3.56

4.15

3.9

5.2

—

Polypectomy (DHB20)

249

0.28

4.14

2.1

4.5

—

Thyrotoxicosis, other and/or unspecified

104

684

1.53

4.13

3.7

3.8

—

Other specified/unspecified nutritional deficiencies

4.48

4.12

5.7

4.4

—

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

201

2.00

4.12

6.3

3.2

—

Toxic effects of substances chiefly nonmedicinal as to source

374

1.72

4.11

2.4

4.3

—

Haemangioma and lymphangioma, any site

208

1.98

4.11

2.8

3.0

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

571

1.55

4.10

2.7

3.1

—

Idiopathic pulmonary fibrosis

301

1.81

4.09

4.9

4.7

—

Personal history of other diseases and conditions

321

1.78

4.09

3.7

2.9

—

Disorders of adult personality and behaviour

137

955

1.44

4.07

2.6

3.6

—

Schizophrenia

536

1.59

4.07

2.7

3.8

—

Certolizumab pegol

3.57

4.07

3.7

3.6

—

Benign neoplasm of meninges

368

1.72

4.07

4.5

4.0

—

Osteosarcoma, excluding all cancers (controls excluding all cancers)

10.45

4.06

2.4

3.9

—

Benign neoplasm: Connective and other soft tissue of thorax

10.39

4.05

4.3

5.0

—

6.75

4.04

4.7

3.9

—

Other noninflammatory disorders of cervix uteri

169

2.09

4.02

3.0

3.6

—

Malignant neoplasm of kidney, except renal pelvis

347

1.74

4.02

3.7

4.2

—

Other/unspecified reactive arthropathies

224

1.93

4.01

3.3

4.1

—

Cardiomyopathy

104

689

1.52

4.01

3.6

3.8

—

Tuberculosis, wide

282

1.82

3.97

4.5

4.2

—

Functional dyspepsia

139

977

1.43

3.97

3.7

3.8

—

Benign paroxysmal vertigo

163

1180

1.39

3.94

3.4

4.0

—

Superficial injury of ankle and foot

379

1.70

3.93

5.3

4.2

—

Alzheimer’s disease (Late onset)

816

0.59

3.93

4.8

3.7

—

Myocardial infarction

336

1920

1.26

3.93

3.5

3.9

—

Benign neoplasm of middle ear and respiratory system

191

2.00

3.92

2.5

2.8

—

Carcinoma in situ of skin of scalp and neck

2.93

3.92

10.8

2.9

—

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

3.47

3.91

3.9

3.7

—

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

3.47

3.91

5.8

3.1

—

Unspecified mental disorder

212

1599

1.33

3.91

2.8

3.8

—

Other and unspecified nonorganic psychotic disorders

589

1.55

3.91

3.5

—

Campylobacter enteritis

2.59

3.90

3.5

4.1

—

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

262

1.84

3.89

3.2

—

Diabetic retinopathy, strict definition

109

643

1.50

3.89

3.7

3.4

—

Redundant prepuce, phimosis and paraphimosis

110

739

1.49

3.89

3.1

4.0

—

Intracranial injury

334

2582

1.25

3.88

3.5

3.7

—

Diabetic retinopathy

203

953

1.35

3.88

3.7

3.3

—

Optic atrophy

2.82

3.88

7.8

4.2

—

Single spontaneous delivery

124

951

0.69

3.88

3.9

3.3

—

Discitis, unspecified

3.02

3.87

2.8

2.9

—

malignant neoplasm of male genital organs

277

1367

1.29

3.87

3.2

4.1

—

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

6.28

3.87

1.9

3.4

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

270

1.82

3.86

3.2

—

Coxarthrosis, primary

366

2567

1.24

3.85

3.8

—

Persistent mood disorders

104

696

1.50

3.84

4.1

3.9

—

Osteosarcoma

12.85

3.83

2.3

6.4

—

Bell's palsy

390

1.68

3.82

4.9

4.3

—

Scabies

146

2.14

3.81

4.0

4.1

—

Obesity, other/unspecified

166

1212

1.37

3.81

2.3

3.8

—

Other hammer toe(s) (acquired)

570

1.54

3.80

3.6

3.7

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

2.86

3.80

2.1

2.2

—

Chronic viral hepatitis

133

2.20

3.80

2.8

3.0

—

Neuromuscular dysfunction of bladder

301

1.77

3.79

3.2

4.0

—

Exfoliative dermatitis

3.41

3.79

6.4

4.1

—

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

3.58

3.78

3.3

3.0

—

Dental caries 2, only avohilmo

411

2653

1.22

3.78

3.4

3.5

—

Disorders of oesophagus in diseases classified elsewhere

2.77

3.78

4.8

3.9

—

Chronic hepatitis, not elsewhere classified

108

2.34

3.77

2.6

4.0

—

Oral leukoplakia and related diseases, including avohilmo

324

1.74

3.77

4.1

4.2

—

Benign neoplasm of other and ill-defined parts of digestive system

484

1.60

3.77

4.5

3.0

—

Other metabolic disorders

430

1.64

3.76

5.9

4.2

—

Other leukaemias of specified cell type

7.20

3.76

19.6

4.2

—

Intestinal malabsorption

147

2.13

3.75

3.1

4.0

—

Primary coxarthrosis, bilateral

173

1276

1.36

3.75

3.3

3.9

—

Malignant neoplasm of urinary organs

385

1.67

3.74

3.8

4.2

—

Other obstructive and reflux uropathy

134

2.18

3.74

5.3

4.7

—

Other demyelinating diseases of the central nervous system

2.42

3.73

3.8

3.6

—

Nonischemic cardiomyopathy

209

1.93

3.73

3.1

4.8

—

Migraine

231

1507

1.31

3.73

2.4

3.4

—

Malignant neoplasm of oral cavity

115

2.29

3.73

4.0

4.1

—

Complications following abortion and ectopic and molar pregnancy

2.47

3.73

3.4

3.2

—

Deep endometriosis

296

1.77

3.70

2.3

3.6

—

Allergic contact dermatitis

440

1.62

3.69

2.8

3.7

—

Tongue abnormality

217

1.91

3.69

4.7

3.9

—

Alcohol dependence

152

1101

1.39

3.68

2.5

4.1

—

Calculus of lower urinary tract

203

1.94

3.68

3.7

4.4

—

Scleritis and episcleritis

182

1.99

3.68

3.5

3.8

—

Pustulosis palmaris et plantaris

122

2.23

3.68

2.3

4.0

—

Infective bursitis

2.40

3.67

3.0

4.0

—

Other degenerative diseases of the nervous system

154

843

1.39

3.66

4.0

3.8

—

Unspecified nephritic syndrome

2.64

3.66

4.2

3.7

—

Status epilepticus

116

2.26

3.65

4.0

5.1

—

Chorioretinal inflammation

2.45

3.65

2.9

3.9

—

Carcinoma in situ of skin of trunk

2.63

3.65

10.1

2.8

—

Lichen simplex chronicus

110

2.30

3.63

3.2

4.4

—

Dental pulpitis 4, only avohilmo

699

3130

1.17

3.60

3.4

3.6

—

Benign neoplasm: Descending colon

163

2.04

3.60

3.8

3.1

—

Benign neoplasm of mouth and pharynx

405

1.64

3.59

4.0

3.8

—

Malignant neoplasm of head and neck

314

1.73

3.59

3.6

4.2

—

Urethral stricture

198

1.93

3.58

4.7

4.5

—

Isolated proteinuria

2.42

3.57

3.0

3.8

—

Benign neoplasm: Larynx

2.67

3.57

1.6

3.2

—

Mouth breathing

137

1890

0.72

3.57

3.9

—

Myositis

2.47

3.57

4.8

—

Other disorders of breast

398

1.64

3.56

2.8

3.6

—

Impetigo

137

2.14

3.56

4.1

3.8

—

Other diseases of peritoneum

144

2.10

3.54

3.0

4.0

—

Alzheimer disease, including avohilmo

113

1166

0.70

3.53

4.7

3.7

—

Kela-code for severe mental illness

192

1452

1.33

3.53

2.8

3.8

—

Hydrocele

438

1.61

3.52

4.8

4.0

—

Propionic acid derivatives

184

684

1.36

3.52

3.7

4.7

—

Alcohol-induced chronic pancreatitis

221

1.87

3.50

2.2

4.8

—

Traumatic subdural haemorrhage

462

1.58

3.50

4.0

4.1

—

Vascular disorders of the intestines

221

1.87

3.49

2.9

3.8

—

Autoimmune hyperthyroidism

145

2.08

3.47

3.1

3.8

—

Disorders of endocrine glands in diseases classified elsewhere

7.69

3.46

4.6

6.1

—

Subjective visual disturbances

130

929

1.40

3.44

3.2

3.9

—

Asthma, including avohilmo

724

3637

1.16

3.44

3.3

3.6

—

Disorder of external ear, unspecified

100

2.33

3.44

2.7

4.5

—

Malignant neoplasm of accessory sinuses

7.55

3.44

1.7

4.0

—

Heart failure and coronary heart disease

218

1250

1.30

3.44

4.2

3.9

—

Personality disorders

126

896

1.41

3.43

2.7

3.6

—

Other complications of labour and delivery, not elsewhere classified

236

0.33

3.43

2.3

2.7

—

Vitamin B12 deficiency anaemia

387

1.64

3.42

3.1

4.1

—

Bulimia nervosa (incl. atypical)

2.68

3.40

3.3

3.7

—

Benign neoplasm: Skin of trunk

2.41

3.40

5.0

3.7

—

Carcinoma in situ, bladder

2.47

3.39

5.7

3.2

—

Malignant neoplasm of nasal cavity and sinuses

3.83

3.39

8.1

4.3

—

Use of fingolimod

5.10

3.39

2.2

4.5

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

156

1152

1.36

3.39

3.2

4.2

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

209

1.88

3.39

3.5

4.5

—

Right hemicolectomy

231

1.83

3.38

2.8

4.2

—

Pleural plaque

404

1.62

3.38

5.9

3.8

—

Other and unspecified mood [affective] disorders

174

1.96

3.38

1.9

3.6

—

Cardiomyopathy in other diseases

5.93

3.38

4.1

6.1

—

Acute mastoiditis

3.79

3.38

3.3

3.1

—

Delivery

130

957

0.72

3.38

3.9

3.3

—

Tinnitus

127

908

1.40

3.37

3.8

4.0

—

Beningn neoplasm: Meninges, unspecified

3.29

3.36

5.3

4.1

—

Other eating disorders

127

2.14

3.36

4.1

3.7

—

Other orthopaedic follow-up care

168

1.98

3.34

2.5

4.2

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

2.65

3.32

6.1

3.6

—

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

2.64

3.31

2.4

3.3

—

Other diseases of spinal cord

102

2.28

3.30

5.0

4.4

—

Dementia in other diseases classified elsewhere

169

1.97

3.30

2.5

4.4

—

Alzheimer’s disease, wide definition

871

0.64

3.29

4.2

3.6

—

Post-traumatic stress disorder

190

1.90

3.28

3.3

3.2

—

Amenorrhoea

169

1.96

3.28

2.5

2.9

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

2.31

3.27

4.4

3.8

—

Dissociative [conversion] disorders

2.31

3.27

3.0

3.5

—

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

219

1.84

3.27

2.3

3.1

—

Tuberculosis

241

1.80

3.27

4.3

4.1

—

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

323

1.68

3.26

2.8

3.2

—

Deep bite

376

1.59

3.25

3.0

3.9

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

3.22

3.23

4.9

3.1

—

Benign neoplasm: Long bones of lower limb

2.69

3.23

2.4

4.1

—

Actinomycosis

6.64

3.22

5.7

2.4

—

Eating disorder

227

1.81

3.22

3.3

3.1

—

Implicit parasitic Sepsis

6.59

3.22

3.6

5.9

—

Acute gastritis

257

1.76

3.21

3.3

3.7

—

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

3.63

3.21

2.2

2.1

—

Chondromalacia

2.29

3.21

2.2

3.6

—

Vulvovaginal ulceration/inflammation in other diseases

123

2.13

3.20

3.1

3.4

—

Any prescribed medicine buy

8.05

3.19

5.1

1.0

—

Crossbite

266

1.72

3.18

4.8

3.6

—

Impacted teeth

507

1.51

3.17

4.1

2.9

—

Deviated nasal septum

186

1424

1.31

3.17

4.4

3.7

—

Malignant neoplasm of digestive organs

229

1774

1.27

3.17

2.7

3.9

—

Special screening examination for other diseases and disorders

207

1.84

3.16

3.6

2.8

—

Social phobias

200

1.86

3.15

3.2

3.8

—

Erosion and ectropion of cervix uteri

2.43

3.15

2.3

3.8

—

Bitten or struck by other mammals

342

1.65

3.14

4.9

4.0

—

Atopic dermatitis, strict definition

142

1026

1.36

3.14

3.2

3.6

—

Malignant melanoma of skin

436

1.57

3.14

4.7

4.0

—

Benign neoplasm of breast

274

1.72

3.13

2.7

3.1

—

Thyrotoxicosis with diffuse goitre

452

1.55

3.12

3.6

4.0

—

Eating disorders

304

1.68

3.12

3.0

3.3

—

Fall on and from stairs and steps

137

1007

1.36

3.10

4.1

—

Hyperfunction of pituitary gland

145

2.01

3.10

6.3

3.7

—

Other inflammation of eyelid

453

1.55

3.10

5.1

4.1

—

Nonorganic sleeping disorders, excluding more controls

549

1.50

3.10

2.8

3.9

—

Malignant neoplasm of bone and articular cartilage of limbs

5.23

3.10

2.3

4.4

—

Open wound of ankle and foot

336

1.65

3.09

3.4

4.2

—

Other and unspecified injuries of shoulder and upper arm

2.35

3.09

4.0

—

Acne

275

1.71

3.08

3.5

3.1

—

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

3.28

3.07

3.3

3.9

—

Dental pulpitis 1, only avohilmo

693

3146

1.15

3.05

3.4

3.6

—

Malignant neoplasm of other and unspecified parts of biliary tract

2.95

3.05

2.7

3.9

—

Thyrotoxicosis

130

951

1.37

3.04

3.7

—

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

338

1.63

3.02

3.3

3.2

—

Chronic nephritic syndrome

140

2.02

3.01

5.9

4.2

—

Benign neoplasm: Spinal meninges

4.37

3.01

2.8

3.8

—

Superficial injury of lower leg

124

902

1.38

3.01

3.3

3.9

—

Malignant melanoma

586

1.47

3.00

4.4

4.3

—

Ingrowing nail

168

1.92

3.00

4.4

3.8

—

Disorders of puberty, all

2.78

3.00

4.0

5.4

—

Entropion and trichiasis of eyelid

316

1.66

3.00

3.6

4.6

—

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

2.77

2.99

6.3

3.7

—

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

2.77

2.99

4.6

3.7

—

Emotional disorders and disorders of social functioning with onset specific to childhood

173

1.89

2.98

4.1

3.2

—

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

2.42

2.97

2.9

3.9

—

Basal cell carcinoma, including avohilmo

347

2262

1.21

2.96

4.8

3.6

—

Abnormal findings on examination of urine, without diagnosis

155

1.95

2.95

3.4

4.5

—

Dermatopolymyositis, unspecified

4.87

2.95

5.5

3.6

—

Benign neoplasm: Transverse colon

388

1.58

2.94

3.0

4.2

—

Miliary tuberculosis

7.22

2.93

2.3

5.1

—

Blindness, monocular

3.41

2.93

5.0

4.5

—

Covid-19 suspected case

688

1.43

2.93

3.8

3.6

—

Endometriosis of ovary

539

1.49

2.92

2.9

3.0

—

Lactose intolerance

2.23

2.91

1.8

4.3

—

Superficial injury of shoulder and upper arm

389

1.58

2.90

4.3

4.1

—

Benign neoplasm: Connective and other soft tissue of thorax

5.58

2.90

4.3

3.4

—

Pyoderma

2.46

2.89

4.7

4.1

—

Benign neoplasm: Cerebral meninges

327

1.63

2.89

4.1

3.7

—

Papilloedema, unspecified

2.46

2.89

4.9

3.5

—

Respiratory tuberculosis, confirmed

2.62

2.89

6.7

3.6

—

Emotional disorders starting during childhood or adolescence

155

1.93

2.88

4.4

3.5

—

Endometriosis of rectovaginal septum and vagina

251

1.72

2.88

2.4

3.3

—

Alcohol abuse, main dg

534

1.48

2.88

1.9

4.2

—

Anosmia

3.13

2.87

4.1

1.9

—

Superficial injury of forearm

320

1.63

2.86

4.1

—

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

2.95

2.86

1.4

3.1

—

Trigger finger

470

1.52

2.86

3.2

4.0

—

Other benign neoplasms of connective and other soft tissue

244

1.73

2.86

3.1

3.2

—

Disturbances of skin sensation

129

954

1.36

2.84

2.9

3.6

—

Endometriosis ASRM stages 3,4

108

776

1.40

2.84

2.7

3.4

—

Basal cell carcinoma

336

2220

1.21

2.84

4.7

3.6

—

Malignant neoplasm of heart, mediastinum and pleura

2.82

2.84

5.6

3.8

—

Malignant neoplasm of prostate

264

1344

1.24

2.84

3.2

4.2

—

Suggestive for eosinophilic asthma

321

1.63

2.84

3.4

4.3

—

Other aneurysm

208

1.79

2.83

3.2

4.5

—

Blindness or visual impairment, binocular

4.61

2.83

3.1

4.1

—

Paralytic ileus

123

2.05

2.82

3.7

—

Oral leukoplakia, including avohilmo

2.25

2.81

3.8

4.1

—

Felty syndrome

4.05

2.81

5.9

3.7

—

Focal brain injury

201

1.80

2.81

5.0

5.2

—

Acne vulgaris

201

1.80

2.81

2.5

3.0

—

Common variable immunodeficiency

4.03

2.80

3.7

3.5

—

Kaposi sarcoma, excluding all cancers (controls excluding all cancers)

8.93

2.80

4.2

5.8

—

Benign neoplasm of other and unspecified sites

2.48

2.79

5.6

3.6

—

Nonpyogenic thrombosis of intracranial venous system

3.99

2.79

8.3

4.3

—

Asthma and allergy, excluding more controls

280

1.66

2.79

3.1

2.8

—

Benign neoplasm: Skin of other and unspecified parts of face

409

1.55

2.79

4.5

4.1

—

Vitreous haemorrhage

346

1.60

2.79

5.0

4.0

—

Childhood asthma (age<16), excluding more controls

205

1.71

2.78

3.8

2.2

—

Symptoms and signs involving speech and voice

177

1375

1.29

2.77

2.9

3.9

—

Superficial injury of head

121

890

1.36

2.77

2.8

4.2

—

Other congenital malformations of the digestive system

201

1.80

2.77

3.7

4.6

—

Benign neoplasm of other and unspecified female genital organs

124

2.03

2.76

2.5

3.5

—

Pure hyperglyceridaemia

2.34

2.76

4.3

4.7

—

Status post-ami

303

0.46

2.74

4.6

4.3

—

Childhood asthma (age<16)

206

1.70

2.74

3.8

2.2

—

Universal erythroderma, KELA reimbursement

2.64

2.72

2.9

4.5

—

Nephrotic syndrome

125

2.02

2.72

3.7

4.0

—

Sequelae of injuries of neck and trunk

2.16

2.72

2.4

3.7

—

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

2.53

2.71

1.8

2.2

—

Acquired absence of organs, not elsewhere classified

3.03

2.71

4.7

3.3

—

Scleritis

3.02

2.71

3.1

3.6

—

Nummular dermatitis

279

1.66

2.70

2.9

3.8

—

Paroxysmal tachycardia

109

667

1.38

2.70

4.6

3.5

—

Benign neoplasm: Prostate

4.32

2.70

3.0

4.3

—

Fibrosis of liver

3.86

2.70

3.9

3.6

—

Alzheimer disease

1025

0.72

2.69

5.1

3.7

—

Carcinoma in situ of skin of other and unspecified parts of face

295

1.64

2.69

7.8

4.1

—

Type 1 diabetes

133

997

1.34

2.68

3.9

—

Other and unspecified nerve root and plexus disorders, also in other diseases

651

1.42

2.67

3.4

4.0

—

Isolated proteinuria with specified morphological lesion

2.85

2.67

2.9

3.9

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

327

2150

1.20

2.66

4.7

3.6

—

Other disorders of central nervous system

3.18

2.66

3.5

—

Disorders of puberty

2.83

2.66

2.1

5.3

—

Varicella [chickenpox]

147

1.92

2.66

6.0

4.8

—

Other meningitis

2.83

2.65

3.1

2.8

—

239

1820

1.24

2.65

5.3

3.7

—

Sequelae of injuries of head

176

1.83

2.64

2.8

4.8

—

Brain glioblastoma and astrocytoma

2.58

2.63

4.0

4.1

—

Drug-induced adrenocortical insufficiency

2.58

2.63

3.3

4.3

—

Benign neoplasm: Orbit, unspecified

4.78

2.62

3.6

3.0

—

Benign neoplasm: Orbit, unspecified

4.78

2.62

3.6

3.4

—

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

4.78

2.62

1.3

3.9

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

120

2.02

2.61

5.2

3.8

—

Other and unspecified nonscarring hair loss

4.77

2.61

1.4

3.1

—

Congenital absence, atresia and stenosis of small intestine

7.84

2.61

1.6

5.7

—

Rheumatoid lung disease

4.18

2.61

7.9

4.0

—

Umbilical hernia

147

1125

1.31

2.60

3.8

3.9

—

Emphysema

244

1.69

2.60

4.0

4.7

—

Kaposi sarcoma

7.64

2.59

4.2

3.1

—

Other menopausal disorders

572

0.67

2.59

3.5

3.1

—

Background retinopathy and retinal vascular changes

2.33

2.59

1.8

4.2

—

Disorders of plasma-protein metabolism, not elsewhere classified

4.10

2.59

11.5

4.5

—

Nonalcoholic steatohepatitis

4.09

2.59

1.8

4.9

—

Fluid overload

5.73

2.58

1.3

4.3

—

Unspecified/other endometriosis

237

1.69

2.57

3.0

3.3

—

Supernumerary teeth EXCLUDE clefts and syndromes

5.62

2.56

1.5

7.6

—

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

2.37

2.56

4.8

3.8

—

Cachexia

5.60

2.56

1.5

3.3

—

Episcleritis

149

1.89

2.56

3.4

3.7

—

Dislocation, sprain and strain of joints and ligaments of knee

307

2375

1.20

2.56

3.1

3.6

—

Other extrapyramidal and movement disorders in other diseases

121

903

1.34

2.56

2.7

4.1

—

Failed induction of labour

114

2.03

2.56

2.7

3.4

—

Agoraphobia

2.37

2.56

4.0

3.8

—

Other disorders of eyelid

250

1974

1.23

2.55

3.3

3.8

—

Brain meningioma

171

1.83

2.55

3.4

3.7

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

3.10

2.55

8.7

4.2

—

Speech and linguistic disorders, excluding more controls

245

1.66

2.55

5.2

3.6

—

Cushing syndrome

3.08

2.54

5.1

4.0

—

Carcinoma in situ of colon

3.08

2.54

2.6

4.8

—

Biological medicines for asthma

3.07

2.54

1.5

3.1

—

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

3.07

2.53

4.3

4.1

—

Asthma and allergy

288

1.62

2.53

3.1

2.8

—

Other benign neoplasms of uterus

186

1.79

2.53

2.5

3.5

—

Alcohol withdrawal state with delirium

246

1.68

2.53

1.7

4.5

—

Benign neoplasm: Stomach

246

1.67

2.52

5.1

3.2

—

Appendectomy

333

2697

1.19

2.52

3.8

3.5

—

Complications of other internal prosthetic devices, implants and grafts

115

2.02

2.51

4.0

4.1

—

Degenerative diseases of the nervous system

117

1175

0.75

2.51

4.7

3.7

—

Memory loss

355

0.48

2.51

3.3

4.3

—

Oral lichen ruber planus wide, hypothyreosis or thyroxin

172

1.82

2.51

3.0

3.6

—

Exophthalmic conditions

3.52

2.49

3.0

4.6

—

Carcinoma in situ of skin, other sites/unspecified

3.52

2.49

5.3

2.8

—

Other enthesopathies

146

1124

1.30

2.49

3.2

3.8

—

Otalgia

278

1.63

2.49

3.4

4.0

—

Lymphangioma, anys site

4.46

2.49

1.3

4.1

—

Fracture of shoulder and upper arm

193

1538

1.26

2.49

3.5

3.8

—

Brain glioblastoma

2.71

2.47

4.0

4.7

—

Mental and behavioural disorders due to cannabinoids

2.40

2.46

2.0

2.4

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

210

1.72

2.46

3.4

3.9

—

Use of amantadine

2.49

2.46

3.8

4.3

—

Polyarthritis, unspecified

116

2.00

2.46

3.0

4.4

—

Benign neoplasm: Cranial nerves

2.48

2.45

2.6

4.2

—

Disseminated intravascular coagulation [defibrination syndrome]

5.22

2.43

4.2

3.5

—

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

3.00

2.43

1.3

7.0

—

Hereditary hypogammaglobulinemia

5.19

2.43

2.0

3.2

—

HSIL lesion of the vagina

2.98

2.42

2.6

3.7

—

Dislocation, sprain and strain of joints and ligaments of thorax

103

2.06

2.42

2.3

3.8

—

Open wound of hip and thigh

103

2.06

2.42

4.2

4.0

—

Other and unspecified vasculitis limited to skin

2.19

2.42

4.9

3.7

—

Prepatellar bursitis

145

1.88

2.42

3.3

4.2

—

Carcinoma in situ of oral cavity, oesophagus and stomach

5.13

2.42

2.5

4.0

—

Ectropion of eyelid

138

1.90

2.42

3.0

4.4

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

138

1.90

2.42

4.2

3.8

—

Abscess of mediastinum

6.67

2.41

1.4

2.0

—

Hyperprolactinaemia

2.18

2.41

7.0

3.2

—

Perichondritis of external ear

2.38

2.40

2.3

4.0

—

Dysplasia of cervi uteri

101

570

1.37

2.40

3.6

2.8

—

Other localized connective tissue disorders

2.37

2.40

6.2

3.7

—

Other disorders starting during childhood or adolecense, excluding more controls

161

1.81

2.40

4.2

3.4

—

Cervicalgia

109

810

1.35

2.39

3.3

3.9

—

208

0.38

2.39

2.9

—

Chronic myeloid leukaemia

4.27

2.39

4.9

3.1

—

Allergic contact dermatitis due to drugs in contact with skin

2.23

2.39

3.6

3.7

—

Retinal vascular occlusion

466

1.47

2.38

3.5

4.2

—

Major coronary heart disease event excluding revascularizations

401

2369

1.17

2.38

3.6

3.8

—

Pre-eclampsia superimposed on chronic hypertension

6.37

2.38

5.6

—

Other general symptoms and signs

130

1.91

2.38

3.1

—

Insomnia

499

1.45

2.38

2.8

4.0

—

Other diseases of arteries and capillaries

321

1.57

2.38

3.4

4.0

—

Benign neoplasm: Tongue

104

2.04

2.37

6.2

4.2

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Leukocyte morphology finding [Identifier] in Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS